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A Study of the Impact of the Physical Properties of Blood on the Interpretation of 
Bloodstain Patterns in Forensic Investigations 
By 
Ira Scott DuBey 
 
Advisor: Thomas A. Kubic, J.D., Ph.D. 
 
There are many situations when the value of the physical characteristics of blood far 
outweighs the information gained from DNA analysis of the bloodstain (Brodbeck, 2012; 
Raymond, Smith and Liesegang, 1996). Analysis of bloodstain patterns at crime scenes or on 
clothing often provides significant information and serves both as investigative aids and as 
evidence presented in court. There has been limited work done to evaluate the potential impact of 
variation in the physical properties of blood on the interpretation of blood spatter patterns. This 
dissertation will expand on previous work and investigate how changes in the physical properties 
of blood, specifically those characteristics that influence flight characteristics and the non-
Newtonian properties of the blood, may affect the bloodstain patterns and therefore the 
interpretation of these patterns during crime scene reconstruction. These properties include 
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Chapter 1. The Problem 
Crime scene reconstruction, especially in crimes of violence, often relies on an 
interpretation of blood spatter patterns at a crime scene. The patterns may help in determining the 
sequence of events as well as the location of the perpetrator(s) relative to the victim(s). This 
interpretation is typically based on the blood spatter pattern that is produced when blood is cast 
off of a weapon and onto a surface, which is a dynamic situation, or when blood comes directly 
from a primary source onto a surface, a passive situation. Bloodstain pattern analysis takes into 
consideration how the bloodstains were formed and makes assumptions regarding the physical 
characteristics of human blood. The information provided by an evaluation of bloodstain patterns 
may include the nature of the weapon that was used, the number of blows sustained by the 
victim(s), the position of and the movements of the victim(s) and assailant(s) during and after the 
attack, the sequence of wounds, whether there is more than one crime scene, and other 
information. When this information is combined with all of the available physical evidence, it 
may allow for a reconstruction of the events prior to, during, and following the event. Bloodstain 
pattern analysis is a scientific endeavor employing the principles of biology, physics, and 
mathematics in the analysis. 
The three basic categories of bloodstain groups were classified by MacDonell in 1971 
and were based on the correlation between the velocity of the impacting force generating the 
blood droplets and the size of the resulting bloodstains. 
1. Low velocity impact spatter is created when a source of liquid blood is subject to a force with 
a velocity of up to 5.0 ft/s. Primary stains measuring 3.0 mm or greater in diameter are 





2. In medium velocity impact spatter, bloodstains are created when a source of liquid blood is 
subject to a force with a velocity between 5.0 and 25.0 ft/s. Primary stains have a diameter 
between 1.0 and 3.0 mm and are indicative of blunt force trauma. 
3. In high velocity impact spatter, bloodstains are created when a source of liquid blood is 
subject to a force with a velocity greater than 100.0 ft/s. The primaries stains measure 1.0 
mm or less in diameter and are indicative of firearms, explosions, and high speed machinery 
(MacDonell, 1971). This classification based on velocity is no longer used; it has been 
replaced by the taxonomy described below. 
James in 2005 developed a logically configured taxonomic key for bloodstain patterns 
(James et al., 2005). The primary bloodstain pattern categories are as follows: passive/gravity, 
spatter, and altered. The sub-categories for these are: 
 Passive/Gravity: contact, drop(s), flow, saturation/pooling, and free falling volume. All of 
these bloodstain patterns are formed under the influence of gravity. 
 Spatter: impact, secondary, and projection mechanisms. The bloodstains in this category 
result from active events such as gunshot and cast-off from an object, such as a knife or bat 
(Brodbeck, 2012). 
 Altered: clotted, diluted, dried, diffused, insect artefacts, sequencing and void patterns (James 
et al., 2005) 
There is a further refinement of the spatter mechanisms as follows: 
 Spatter – secondary mechanisms: satellite spatter; 
 Spatter – impact mechanisms: gunshot, beating/stabbing, power tools, etc.; and 





The interpretation of blood pattern spatter relies upon the pattern that the blood makes 
when it impacts a surface. The contact surface characteristics may render the pattern to be of 
little or no value in reconstruction and is an important consideration in evaluating which stains 
are useful for this purpose. The angle of impact is calculated based on a trigonometric calculation 
of the arcsine of the width divided by the length of a blood spatter. An investigator would 
determine these angles from a number of blood spatters and then reconstruct by triangulation of 
the trajectories to determine the point at which those blood spatters originated, for example the 
position of a knife or bat from which the blood was cast off at the time it changed direction. The 
assumptions are based on “normal” blood’s physical and biological parameters.  
The use of blood spatter analysis (BSA) as an aid in the reconstruction of crime scenes 
was used by Dr. Paul Kirk in the State of Ohio vs. Samuel Sheppard murder case in 1955. In his 
affidavit, Dr. Kirk described the position of the accused and the victim at the time the blood 
spatter was produced (Bevel & Gardner, 2002; James et al., 2005). In 1971, Herbert Leon 
MacDonell co-authored Flight Characteristics and Stain Parameters of Human Blood with 
Bialousz (MacDonell & Bialousz, 1971). The research for the book was funded by a Law 
Enforcement Assistance Administration (LEAA) grant. Also in 1971, MacDonell authored 
Interpretation of Bloodstains – Physical Considerations in Legal Medicine (MacDonell, 1971). In 
2002, the Federal Bureau of Investigation (FBI) funded the formation of a scientific working 
group on bloodstain pattern analysis, SWGSTAIN (James et al., 2005). 
Blood is a fluid with a suspension of solid particles in the plasma liquid component  
(Ciofalo et al., 2002). There are three types of formed cellular elements in blood - red blood cells 
(erythrocytes), white blood cells (leukocytes), and platelets (thrombocytes). The cellular potion 





approximately 55% (Rodak, 2002). Erythrocytes contain hemoglobin and transport oxygen from 
the lungs throughout the body. There are about 30 trillion erythrocytes circulating in the normal 
human blood at any given time. Leukocytes serve to defend the body against bacteria, viruses, 
and microorganisms. Leukocytes can be divided into granulocytes and nongranulocytes. 
Granulocytes are further divided into neutrophils, eosinophils, and basophils. Nongranuloctes 
include lymphocytes and monocytes (Dailey, 2001). There are about 430 billion leukocytes 
circulating in the normal human blood at any given time. Thrombocytes play a major role in 
hemostasis and control bleeding by blood clot formation. Plasma provides the medium for 
circulation of the cellular components of blood as well as other solutes. Plasma is comprised of 
approximately 90% water, 8% soluble protein, and 1% organic acids and salts (Bevel & Gardner, 
2002). Albumin accounts for 60% of the plasma protein and contributes to osmotic pressure 
(Marieb, 2003). If the cellular component of blood is removed, the plasma can be regarded as a 
Newtonian fluid and has a viscosity of about 1.6 times that of water (Ciofalo et al., 2002). 
Biorheology is the study of the fluid dynamics of biological fluid. Vogel defines blood as 
a complex, multidimensional continuum of a non-Newtonian fluid and viscoelastic solids 
(Vogel, 1996). A Newtonian fluid shows a linear relationship between applied shear stress and 
strain rate. In non-Newtonian fluids, the shear stress and strain rate are nonlinear; therefore, there 
is no constant coefficient for viscosity (Vogel, 1996). Blood is a non-Newtonian fluid with its 
suspension of cells in plasma and a dynamic viscosity that is not dependent on shear strain rate; 
therefore, the shear stress is not proportional to the shear rate (Eckmann et al., 2000). Blood 
exhibits viscoelasticity, elasticity, thixotropic response, and shear thinning. The microdynamics 
of the erythrocytes account for the viscoelasticity, thixotropic, and shear thinning of blood 





Drop formation of a non-Newtonian fluid can be attributed to surface tension, cohesion, 
and viscosity (Wonder, 2001). In the absence of any opposing forces, surface tension will form a 
drop of liquid into a sphere, which offers the smallest surface area for a specific volume and 
prevents the droplet from separating (Dillard & Goldberg, 1978). The flight of the blood droplet 
through air and the shape of the stain on the receiving surface are directly influenced by surface 
tension (Raymond, 1997). Relative density (d, specific gravity) for a fluid is the measure of its 
weight per unit volume, expressed as d = m/v, where m = mass and v = volume. Whole human 
blood has a density of 1.060 g/cm3, which is 6% greater than water (James et al., 2005). The 
frictional force that exists between adjacent layers of fluids as they move past one another 
creates the resistance to flow. A deformation (shear strain) occurs when force (shear stress) is 
applied to a volume of material (Chaplin, 2007). Increasing the concentration of a dissolved 
substance in a fluid generally increases the viscosity. For example, an increase in the number of 
erythrocytes in a volume of plasma makes the blood thicker and increases its viscosity (Chaplin, 
2007). 
Hematocrit or packed cell volume is the percentage of the volume of red blood cells in 
relation to the volume of plasma (Rodak, 2002). “Normal” adult hematocrit values range from 
35% to 54% (Dailey, 2001). Hematocrit value is important because blood viscosity is considered 
to be a function of the hematocrit value (Raymond, 1997; Bevel et al., 2002). As the hematocrit 
value increases, there is a disproportional increase in blood viscosity; a 50% increase in the 
hematocrit value can result in a 100% increase in viscosity (Kalbunde, 2005). 
Plasma is the portion of the blood in which the cellular elements are suspended. A change 
in plasma viscosity affects blood viscosity regardless of the hematocrit. Plasma is a Newtonian 





pathophysiological conditions and is closely related to the protein content of plasma (Baskurt et 
al., 2003). 
The use of bloodstain pattern analysis as an aid in crime scene reconstruction may 
provide much useful information, including areas of convergence and origin of bloodstains, type 
and direction of impact, and mechanisms by which bloodstains and patterns were produced. This 
information affords an understanding on how blood was deposited onto particular items; the 
position of the victim, assailant, and items located within the scene relative to one another during 
the event; and possibly the movement of the victim, assailant, or other items post event. This 
additional information, along with post mortem findings, will support or contradict statements. 
The evaluation of the information determined from the bloodstain pattern analysis must be 
further evaluated in conjunction with all other physical evidence before concluding the sequence 
of events and the crime scene reconstruction (Raymond et al., 2001; Bevel & Gardner, 2002; 
James et al., 2005). 
There has been little work done on how changes in the physical properties of blood may 
have an impact on bloodstain patterns. Physical properties of blood may change when an 
individual has a blood disorder or disease or when an individual is taking certain therapeutics. In 
an aging population, the incidence of individuals developing blood disorders increases, and 
likewise, more individuals are prescribed therapeutics for these conditions. Additionally, it is 
reasonable to assume that some victims of violent crime will fall into this category.  
This research study evaluated changes in the physical characteristics of blood and how 
this impacted the interpretation of bloodstain patterns in forensic investigations. The principal 
question is whether the blood spatter pattern calculations are valid in situations where the 





changes in the physical and biological characteristics of the donor’s blood cause the blood spatter 
pattern to be modified, whereby the angle calculations and interpretation of the scene are 
incorrect, possibly resulting in an erroneous conclusion as to the reconstruction of events by the 
crime scene investigator? 
The Significance of the Problem 
The conclusions that a crime scene investigator makes regarding blood spatter patterns 
are based on the assumption that the physical properties of blood are constant or normal. The 
question of whether blood was not in the normal range of physical parameters, possibly as a 
result of disease or therapeutic agents, has yet to be considered and reported thereon. Could these 
factors have an influence on the bloodstain patterns produced by the blood and therefore on the 
forensic interpretation of the patterns? 
Examples of diseases that impact the physical properties of blood are described below. 
Hyperviscosity syndrome (HVS) is manifested by increased plasma viscosity typically as a result 
of increased circulating serum immunoglobulins. HVS can also result from increased cellular 
blood components, whether white or red blood cells, in a hyper-proliferative state (Hemingway, 
2014). In general, hyperviscosity occurs from pathologic changes of the cellular or protein 
fractions of the blood. Examples of this syndrome include polycythemias, multiple myeloma, 
leukemia, Waldenstrom macroglobulinemia, sepsis, monoclonal gammapathies, rouleau 
formation, post splenectomy, altered shape of erythrocytes, antibody-mediated erythrocyte 
damage, increased leukocyte count, thrombocytosis, hyperlipoproteinemia, hyperfibrinogenemia, 
hypercyrofibrogenemia, macroglobulinemia, myeloma, amyloidosis, polyclonal hyperviscosity 





associated with cirrhosis, chronic active hepatitis, acute burns, and sickle cell anemia (Adams et 
al., 2009; Wu, 2006). 
Polycythemia, which literally translates into “too many cells in the blood,” is a disease 
state in which the proportion of blood volume that is occupied by red blood cells increases. It can 
be due to an increase in the number of red blood cells, which is absolute polycythemia, or to a 
decrease in plasma volume, which is relative polycythemia (Tefferi, 2003). 
With rheumatic diseases, increased plasma viscosity has been identified, such as in 
patients with rheumatoid arthritis. The average increase in plasma viscosity in active chronic 
cases was 11%, 30% in subactive cases, and 60% in acute cases (Walitza, 1980). 
Elevations in plasma viscosity also correlate to the progression of coronary and 
peripheral artery diseases (Kesmarky, et al., 2008). 
Though not a focus of my research, studies on therapeutic agents that alter blood physical 
characteristics can provide insight because research on disease states with altered blood physical 
characteristics is limited. Examples of therapeutic agents that have an effect on the physical 
properties of blood are described below. 
Warfarin is a widely prescribed drug used to prevent the formation and migration of 
blood clots. It is the most extensively prescribed anticoagulant drug in North America with 
annual prescriptions in the United States of approximately 2 million (Holbrook et al., 2005). 
Warfarin inhibits the vitamin K-dependent synthesis of biologically active forms of the calcium-
dependent clotting factors II, VII, IX, and X, as well as the regulatory factors protein C, protein 






Erythropoietin (EPO) is a naturally occurring hormone that stimulates red blood cell 
production. Recombinant EPO (rEPO) is a synthetic version of this hormone (Waite & Fine, 
2007). EPO therapy is utilized in a number of medical conditions, including anemia and platelet 
disorders, where it is thought that EPO may increase platelet numbers (Harmening, 1997). 
The effect of changes in the physical properties of blood and the possible impact of blood 
disorders on blood pattern analysis is an underexplored area within the field of forensic science 
and requires further scientific investigation due to bloodstain analysis’ inclusion in legal 
proceedings (Brownson & Banks, 2010). This research studied the physical properties of blood 
and the potential impact of variations in the physical properties on bloodstain patterns in forensic 
investigations. The significance of the problem could be great if blood that is outside the normal 
range of physical properties behaves in a manner such that incorrect conclusions could be made 
from crime scene investigations utilizing blood spatter patterns. 
Past Work Related to the Problem 
There have been a number of papers published that discuss the droplet flight and impact 
dynamics of blood; however, none mention the potential errors introduced into the calculations 
by uncertainties in the biological and physical properties of blood (Rogers, 2009). Rogers 
reached the following conclusions based on her hematocrit research. There is a significant 
difference between the determination of x, y, and z coordinate blood spatter values for the 
varying blood hematocrit values. The calculated coordinate values are within “acceptable 
industry limits” (Carter et al., 2006). The hematocrit value was found to affect the width and 
length of the resultant bloodstain; however, a proportional relationship exists such that the 
hematocrit value does not affect the width to length ratio, and therefore, the calculated impact 





The effect of hematocrit value on impact angle calculations is statistically significant, but there is 
close agreement between the known and calculated impact angles irrespective of the hematocrit 
value. Rogers found that the error associated with impact angle calculations for bloodstains 
created using a blood hematocrit range of 11.2% to 68.9% falls within variation stated in the 
literature (Rogers, 2009; Laturnus, 1994; Berel & Gardner, 2002; James et al., 2005). Rogers 
concluded that the hematocrit value significantly affects the bloodstains length and width 
(Rogers, 2009). 
Further study is required to evaluate the distribution and size of bloodstains as a function 
of hematocrit value and applied force and to determine what the impact of changes in the 
physical properties of blood would have on resultant spatter from a gunshot. 
Because there is limited work related to the problem of how changes in the physical 
properties of blood may impact bloodstain pattern analysis, investigators have studied certain 
therapeutic agents and illicit drugs for their ability to produce altered blood physical 
characteristics. The addition of amphetamine to blood at therapeutic to potentially lethal doses 
resulted in a decrease in its dynamic viscosity over the range of 0.5 to 11.0%, respectively 
(Brownson & Banks, 2010). The conclusions from this study were that the physical parameters 
of blood that are presumed to be constant within forensic applications of bloodstain pattern 
analysis play a large role in their interpretation and may have implications in pattern analysis 
(Brownson & Banks, 2010). 
El-Sayed, Brownson, and Banks have studied the effect of warfarin, an anticoagulant that 
is used to prevent thrombosis and embolism, on bloodstain pattern analysis (El-Sayed et al., 
2011). In their study, blood samples were spiked with varying concentrations of warfarin and the 





the inclusion of warfarin results in a change in blood viscosity and surface tension, resulting in 
changes to the calculated angles, heights, and impact velocities of resulting bloodstains when 
utilizing bloodstain pattern analysis to construe such information; however, the alterations 
incurred appear insignificant in our case, thus in terms of an observable alteration in the 
interpretation of bloodstain pattern analysis, this is likely highly improbable.” (El-Sayed, 2011). 
Since blood is a non-Newtonian fluid, the reduction in viscosity from the presence of warfarin 
will change the way blood flows and this may have implications in spatter or droplets that result 
from a gunshot (El-Sayed, 2011). 
The potential impact of changes in the physical properties of blood and how this may 
impact the interpretation of blood spatter produced from the impact of a projectile fired from a 
firearm into tissue was investigated as part of this research study. The El-Sayed paper notes that 
the energy transfer from a bullet striking a blood source causes the blood to disintegrate into 
small droplets. Changes in blood surface tension and viscosity could alter this disintegration 
process and the droplet size.  
The full implications of changes in the physical properties of blood, including alterations 
in blood viscosity, surface tension, and density, require further investigation to understand what 
impact there would be on the interpretation of bloodstain patterns. 
Research Approach  
This research expanded upon previous work that evaluated how certain biological 
variations in blood impacted the physical characteristics of blood, and therefore, modify resultant 
blood spatter patterns. The physical characteristics evaluated were hematocrit, complete blood 
count, viscosity, contact angle, and relative density. Other evaluations included the 





Components of the study.  
The physical properties of blood were be modified by changing the cellular and/or 
plasma portion of blood samples. Human blood containing an anti-coagulant, sodium heparin, 
was used in this study. Pizzola and De Forest compared blood containing heparin to freshly 
drawn blood without heparin; no statistically significant difference was noted with regards to 
density, surface tension, or viscosity (Pizzola, Roth, & De Forest, 1986). 
Blood spatter studies.  
For blood spatter studies, human blood specimens of very high density, high density, 
normal, low density, and very low density were used. These specimens were used in all of the 
evaluations. Additional specimens were added based on the need to further refine the values. 
Instrumentation.  
The ADVIA® 120 System hematology analyzer (Siemens Healthineers, Erlangen, 
Germany) was used for the measurement of hematocrit, complete blood count, differentials, and 
other cellular components. An Anton Paar DMA 35 density meter (Anton Paar, Graz, Austria) 
was used for the measurement of the relative density of the blood samples (Rosencranz & Bogen, 
2006). An Anton Paar MCR 302 rheometer was used to measure viscosity of the blood samples. 
Software for BSA.  
Virtual stringing methods to determine the area of convergence or region of origin are 
equivalent to manual stringing methods transposed onto a computer. The HemoSpat® (FORidnet 
Software, Ottawa, ON, Canada) bloodstain pattern analysis software and digital measurements of 






The first evaluation consisted of allowing a drop of blood formed using a serological 
pipette to fall only under the influence of gravity onto a smooth paper target. Blood was dropped 
from a height of 150 cm to avoid any issues associated with oscillating blood droplets because 
oscillations have been reported to dampen after 40 cm for passive drops (Raymond et al., 1996). 
The target was adjusted to the following angles: 10, 25, 40, 55, 70, and 90o. The five human 
blood specimens of varying densities were used to form spatter patterns at each target angle with 
an N of 10 for a total of 300 determinations. The extreme situations were initially evaluated and 
any impact on blood spatter patterns evaluated. Each bloodstain was measured using a digital 
caliper and all of the bloodstains were photographed to document their patterns. A statistical 
analysis was conducted to evaluate any differences in the angels of impact between the different 
blood densities. 
Spatter: impact/cast-off.  
The five blood specimens of varying densities were utilized in a simulation of a bat 
striking the point of origin. Each simulation was repeated five times with blood spatter patterns 
being evaluated for each event. A minimum of 10 bloodstains were created for each simulation 
and trajectories determined from these. This evaluation included both manual and digital 
measuring. The process for digital measurements is as follows. A numerical scale was affixed to 
the wall adjacent to the bloodstain to be measured and the bloodstain was photographed with a 
digital camera. The digital image was downloaded into the HemoSpat® computer program and 
the picture was cropped to include the bloodstain and the scale. The middle of the bloodstain was 
identified. The software program measured the bloodstain, and the resultant data was used for the 
angle of impact calculations. A statistical analysis was conducted to evaluate any differences 





areas of origin. Statistical evaluation compared calculated areas of origin using a manual string 
method to the computer generated areas of origin and further compared to the actual areas of 
origin for each event. This phase of the study required 25 events (simulations) for blood source 
evaluation for a total of 250 bloodstain evaluations. 
Spatter: gunshot.  
The five blood specimens of varying densities were used in the gunshot blood spatter 
phase of the study. A 0.38 caliber S and W Model 15 revolver (Smith & Wesson, Springfield, 
MA) was used to simulate a gunshot to the head. Each blood specimen was used in each of 10 
simulations for a total of 50 simulations. The primary evaluation was the distance the spatter 
produced from the gunshot travels. Other patterns were also studied. The extent of evaluation 
depended on the geometry of the bloodstain patterns produced. Statistical analysis and 
comparison of the normal blood to the other blood specimens were conducted. 
Quality assurance.  
Quality assurance (QA) of crime scene analysis is a complicated task given the range of 
potential evidence and the variety of potential scenes. There is no “standard” crime scene or 
evidence, and items may have been subjected to a variety of factors, environmental and others, 
prior to the scene being discovered. “Physical evidence cannot be wrong, it cannot perjure itself, 
it cannot be wholly absent. Only human failure to find it, study and understand it can diminish its 
value.” (Thornton & Kirk, 1974). This thesis recommended an approach to ensure quality 
assurance during the crime scene investigation and evidence recovery process. In particular, a 







Statistical analysis.  
A component of this research involved the comparison of manual measurements of the 
BSA process to digital measurements. The analysis of the data generated from this research was 
used to determine the impact of the physical properties of blood on the interpretation of 
bloodstain patterns in forensic investigations. What are the differences and are they statistically 
significant? Under what conditions or circumstances do they occur? This was related to possible 
implications of blood disorders on bloodstain pattern interpretation.  
Additional areas for research.  
An element of scene reconstruction may be evaluating whether disease state blood is 
present. Is it possible to test the dry bloodstains to evaluate the disease state of the blood donor? 
One option may be to test bloodstains for the presence of therapeutic drugs used to treat the 
targeted disease states to elucidate the underlying disease of the victim or source of the 
bloodstain.  
Research Process 
The following activities were undertaken in order to accomplish this research study: 
1. Obtain human blood components 
2. Prepare blood samples for testing 
3. Obtain instrumentation for density measurements 
4. Utilize instrumentation for cellular component analysis 
5. Construct device to be used in passive bloodstain experiments (Study 1) 
6. Obtain bloodstain analysis software package 
7. Conduct Study 1  





9. Construct room for blood spatter experiments (Study 2) 
10. Construct device to produce blood spatter 
11. Obtain additional human blood components 
12. Prepare blood samples for Study 2 testing 
13. Conduct Study 2  
14. Data analysis of the manual string method and computer modeling 
15. Statistical analysis of data 
16. Construct bloodstain collection unit for gunshot experiments (Study 3) 
17. Conduct Study 3  
18. Data and statistical analysis 
19. Discussion and conclusions 
 
Chapter 2. Study 1: Passive/Gravity 
The purpose of this study was to analyze the statistical relationship between the changes 
in the physical properties of blood, bloodstain geometry, and angle of impact determinations. 
Five different blood samples were utilized and the angles of impact were calculated at the 
following target angles: 10, 25, 40, 55, 70, and 90°. 
Preparation of Blood Samples 
Human blood components were purchased from BioreclamationIVT (BioIVT, Hicksville, 
NY) and consisted of the following: 
 50 mL of human whole blood with sodium heparin added as anticoagulant (Figure 1), 






 25 mL of unfiltered human serum (Figure 3). 
All of the human blood components were tested and found to be negative for the 
following: HIV 1/2 Ab, HCV Ab (hepatitis C), non-reactive for HBsAg (hepatitis B), HIV-1 
RNA, HCV RNA (hepatitis C), HBV DNA, WNV RNA, ANTI-T CRUZI, and STS (syphilis). 
(Certificates of analysis are contained in the Appendix.) All blood was stored at 4 oC until use. 
 
Figure 1. Human whole blood 
 
 






Figure 3.  Human serum 
 
The whole blood was centrifuged to separate the cellular components from the plasma 
using a Model 614B Drucker Laboratory centrifuge (Drucker Diagnostics, Port Matilda, PA). A 
total of nine blood samples were prepared by combining the cellular whole blood components 
with serum in the proportions noted in Table 1.  
 
Table 1. Blood sample preparation for Study 1  
Sample # Cells, % Cells, mL Serum, % Serum, mL 
1 5 0.5 95 9.5 
2 10 1.0 90 9.0 
3 15 1.5 85 8.5 





5 40 4.0 60 6.0 
6 80 8.0 20 2.0 
7 85 8.5 15 1.5 
8 90 9.0 10 1.0 
9 95 9.5 5 0.5 
 
Hematocrit 
For each of the nine samples, the hematocrit (HCT) was determined using the ADVIA 
120 Siemens hematology analyzer (Figure 4 and Table 2). The HCT or packed cell volume 
(PCV) is the volume of red blood cells in relation to the volume of plasma (Rodak, 2002). The 
instrument data printouts are included in the Appendix. 
 







Table 2.  HCT determinations of the prepared blood samples 








8 Measurements not available for 8 and 9 
9 Instrument filter issues 
 
Density 
For each of the nine blood samples, the density was determined by using an Anton Paar 
DMA 35® density meter (Figure 5). The density meter utilizes Anton Paar’s oscillating U-tube 
technology. The sample is introduced into a U-shaped borosilicate glass tube using a disposable 
syringe. The tube is excited to vibrate electronically at its characteristic frequency. The 
characteristic frequency changes depending on the density of the sample (Anton Paar, 2012). The 






Figure 5. Anton Paar Portable Density Meter DMA 35 
 
Table 3. Density determinations 
Sample Number 
Density, g/cm3 at 37 oC 
Mean , N=3 
Standard Deviation 
(SD) 
1 1.0272 0.0001 
2 1.0274 0.0001 
3 1.0299 0.0007 
4 1.0339 0.0027 
5 1.0455 0.0005 
6 1.0677 0.0003 
7 1.0710 0.0020 
 
Five blood samples were selected from the prepared samples to be used in Studies 1-3. 







Table 4. Sample density designations 
Sample number Sample Designation -  Density 
1 VL: very low 
3 L: low 
5 N: normal 
6 H: high 
7 VH: very high 
 
Viscosity 
Viscosity measurements of the five blood samples of varying density were carried out 
using a MCR 302 Rheometer (Anton Paar, USA) (Figure 6). The samples were loaded onto the 
bottom plate using disposable Pasteur pipettes (Figure 7). The temperature was set at 37 oC and 
maintained at this temperature using the peltier temperature-controlled plate. The rheometer uses 
a cone-plate system, and the rotational test was carried out at a shear rate range from 5 s-1   to 500 
s-1 at a constant temperature of 37 oC (Figure 8). The data are presented in Figure 9; the blood 
samples labelled 1 through 5 correspond to (1) very low density, (2) low density, (3) normal 
density, (4) high density, and (5) very high density. To properly characterize the blood samples 
at all five densities, two measuring systems were utilized - a cone with a 50 mm diameter for the 
less dense samples (1, 2, and 3) and a plate with a 25 mm diameter for the more dense samples (4 
and 5). For the flow curve, the viscosity is measured as a function of shear. Blood is a non-
Newtonian fluid and it is shear thinning; as shear increases the viscosity decreases. The results of 
the analysis clearly show that the higher the density, the higher the viscosity. All five blood 







Figure 6. The MCR 302 Rheometer by Anton Paar 
 
 






















Relationship Between Hematocrit, Density, and Viscosity 
For Figures10, 11, 12 and 13, the data points are the five blood samples that were 
prepared for Study 1. From left to right in the graphs, they are designated as per Table 4 as 
follows: (1) very low density, (3) low density, (5)  normal density, (6) high density and (7) very 
high density. The corresponding HCT percentages are contained in Table 2. Figure 10 shows the 
relationship between the density of the blood samples and the HCT of the blood samples. The 
hematocrit is defined as the volume occupied by erythrocytes in a given volume of blood and is 
usually expressed as a percentage of the volume of the whole blood sample. (Harmening, 1997) 
As the HCT increases, the density increases. The R2 value is 0.9928. 
Figure 11 shows the relationship between viscosity at a shear rate of 96.7 s-1 to HCT. The 
viscosity increases significantly above a HCT value of 65%. The R2  value is 0.9578. 
Figure 12 shows the relationship between viscosity at a shear rate of 96.7 s-1 to density. 
The viscosity increases significantly above a density of 1.06 g/cm3, which corresponds with 
blood sample number six of the study, which has a density of 1.0677 g/cm3  (see Table 3). The R2     
value is 0.9774. 
Figure 13 shows the relationship between the log of viscosity at a shear rate of 96.7 s-1  to 
density. The R2  value is 1.0. 







Figure 10. Relationship between density and HCT (hematocrit) 
 
 
Figure 11. Relationship between hematocrit and viscosity. 


































































Figure 12. Relationship between density and viscosity 
 



































Density, g/cm3 vs. Viscosity, mPa/s at 96.7 s-1 shear rate
























Contact Angle and Surface Tension 
Surface tension is the force acting on the surface of a liquid, tending to minimize the 
surface area. It is often observed as the formation of a meniscus in containers or as the formation 
of droplets or bubbles on a surface (Mukherjee et al, 2005). Surface tension is an important 
physical property of blood when evaluating blood spatter, however the surface tension of 
patient’s blood is not assessed in common medical practice (Hrncir & Rosina, 1997). There are a 
number of approaches to determine surface tension. The capillary rise method determines the 
surface tension of a liquid by using capillary tubes. When a capillary tube is placed in a fluid, the 
liquid level in it rises above the normal liquid level. This elevation in the liquid level is a 
function of the surface tension. Capillary action occurs when adhesion to the wall is stronger 
than the cohesive forces between the liquid molecules (Mukherjee, 2005). A second method is 
bubble pressure tensiometry which is based on the measurement of the maximum pressure in a 
bubble growing at the tip of a capillary immersed into the liquid under study. The pressure 
required for the separation of the air bubble from the capillary tip, which drops at the air-liquid 
interfaces, is directly proportional to the surface tension (Zaitsev, 2018). The third method is the 
drop weight method. In this method the drop weights from any one tip are proportional to surface 
tensions, it is only necessary to measure the weight of the falling drop. (Woodward, 1912). 
The contact angle is a quantitative measure of the wetting of a solid by a liquid. It is 
defined as the angle formed by a liquid at the three-phase boundary where a liquid, gas, and solid 
intersect. The Young equation describes the balance at the three phase contact of solid-liquid and 
gas. 





The interfacial tensions, which measure the free energy (per unit area) Ysv, Ysl and Ylv 
form the equilibrium contact angle of wetting, Θy (Adamson & Gast, 1997). Measurements of 
the contact angle of the five blood samples of varying density were obtained on three different 
surfaces: polyethylene, acrylic (PMMA), and Teflon (PTFE). The FTIR scans of the materials 
are contained in the Appendix (see Table 5). 
In order to measure the contact angles of the five blood samples, the following procedure 
was followed. The data collection set up consisted of a Cannon EOS 60D camera with a Cannon 
180 mm L macro lens on a tripod, which was used to photograph a single drop of blood on a 
specific surface (Figure 14).  
 
            
Figure  14. Data collection equipment, showing camera (left) with 180 mm lens aligned to 
target. Note spirit level and target area bubble level to ensure proper alignment. 
 
The camera was set at auto light balance ASA 400 and halogen lights were utilized on a camera 
stand. The camera was focused on a stand that held the approximately 3 inch x 3 inch section of 






       
Figure 15.  Sample images of blood contact angle (left to right): uncleaned glass slide, acrylic, 
HDPE, and PTFE. All polymers were precleaned with acetone, followed by detergent in water, 
followed by water rinse, and drying with clean wipes. 
 
The blood samples were heated in a water bath to 37 oC prior to being dropped onto 
specific surfaces and five drops were placed on each surface and photographed. The total number 
of drops photographed was 5 for each surface on 3 different surfaces for each of the 5 blood 
samples of varying density, for a total of 75 blood drop pictures measured. The measurement of 
the contact angles was made on the computer monitor utilizing a calibrated protractor (Figures 





















Figure 18 is a schematic of measuring the contact angle when the angle is acute (right 
drawing) which indicates a hydrophilic surface and when the angle is obtuse (left drawing) 
which indicates a hydrophobic surface. 
 
 
Figure 18. Contact angle measurement 
 
Table 5 shows as the surface material is more hydrophobic the contact angle increases 
across all blood densities. Increasing contact angles from acrylic (PMMA) to polyethylene 













Table 5. Contact angle measurements of blood of varying densities on polyethylene, acrylic, and 
Teflon surfaces. Each measurement is the mean of n=5. 
 
 
Passive Blood Drop Device Construction 
A device was fabricated to be used for the Study 1 passive blood drops. The purpose of 
this device was to simulate a drop of blood from a fixed height striking a target surface at a 
specific angle. The device was constructed from acrylic panes with a base that measures 24 
inches by 24 inches, 3 walls composed of the same material, and a bottom pane that was hinged 
to allow to movement to specific fixed angles (Figures 19-20). The angles were determined by 
use of a protractor, and holes were drilled in the acrylic panes for the following angles: 10, 25, 
40, 55, 70, and 90o. A total of six angles were used for this phase of the study. Acrylic rods were 
placed in the holes to hold the movable acrylic pane in place at each angle during the testing. 
CONTACT ANGLES
POLYETHYLENE ACRYLIC PMMA TEFLON  PTFE
BLOOD DENSITY MEAN SD MEAN SD MEAN SD
very low 68.8 2.31 73.6 3.01 84.7 1.52
low 73.9 4.58 73.4 3.31 85.8 1.26
normal 75.8 1.76 73.4 1.28 83.2 0.69
high 78.7 1.70 73.3 0.19 83.4 1.08
very high 81.7 0.78 74.2 2.50 84.6 0.98
MEAN 75.8 73.6 84.3

















































Figure 20. Schematic of the passive blood drop collection device 
 
All of the blood samples utilized in the study were maintained at 37 oC in a Precision 
280® series water bath (Thermo Fisher Scientific, Waltham, MA) prior to use. All of the blood 
samples were dropped from a height of 150 cm to eliminate distortion due to oscillation, which 
causes blood droplets to deviate from their spherical shape (Pizzola et al., 1986; Pizzola et al., 
1986a; Raymond et al., 1996a). For free falling droplets, no detectable oscillation was present 
after 40 cm (Raymond et al., 1996a). 
Using a disposable serological pipette containing sample, a drop was allowed to form and 
released for each determination. Each blood sample drop was repeated with a sample size (N) of 
10 for each angle and for each of the 5 densities, for a total of 300 bloodstain determinations. 
The target for this study was premium multipurpose office paper, which is plain, white, smooth 
surface 8 ½ x 11 inch sheet. Pictures of all of the bloodstains are contained in the Appendix; 


































Figure 24. Very low density blood sample dropped at a 10o angle. 
 
 







Figure 26. Normal density blood sample dropped at a 25o angle. 
 
 







Figure 28. Bloodstain 3 (low density) at a 10° angle. 
 
 







Figure 30. Bloodstain 3 (low density) at a 40° angle.  
 
 







Figure 32. Bloodstain 3 (low density) at a 90° angle 
 
 







Figure 34. Bloodstain 6 (high density) at a 25° angle. 
 
 







Figure 36. Bloodstain 6 (high density) at a 55° angle. 
 
 







Observations on Bloodstain Geometry 
A summary of the bloodstain observations is presented in Table 6. 




3 at 10° Elongated tail and secondary tailing 
3 all angles Light red color 
3 at 25° Length and width increased, multiple tails, light red color, cellular 
material concentrated in direction of travel 
3 at 40° Same comments as 25° 
3 at 70° Directionality not clear, dark red zone of cellular material in direction 
of travel 
3 at 90° No directionality, cells separate from serum and form banding pattern, 
color not uniform 
6 at 10° Dark red color, tail present 
6 at 25° No tail 
6 at 40° No tail, difficult to determine directionality, concentration of cellular 
material at one end indicates direction of travel 
6 at 55° Very small tail, dark red color, cellular material concentrated in 
direction of travel 
6 at 90° Uniform color throughout bloodstain 
 
Bloodstain Measurements 
An evaluation was conducted to determine the best approach to the measurement (length 
and width determinations) of the bloodstains for Study 1. First, a stainless steel scale that meets 
the Japanese Industrial Standard (JIS) grade 1 of JIS B 7516-2005 was considered. The scale has 





the bloodstains was the use of a digital caliper that measures to 0.01mm (see digital caliper 
specifications in the Appendix). An evaluation of the two measuring devices was conducted to 
compare their accuracy and precision. The digital caliper and the steel scale were utilized to 
make ten measurements of 4.5 mm and ten measurements of 120 mm. The results of the 
measurements are contained in Table 7. The measurements of 4.5 mm using the digital caliper 
had an error of 5.78% compared to the steel rule which had an error of 11.11%. The 
measurements of 120 mm using the digital caliper had an error of 0.27% compared to the steel 
rule which had an error of 0.33%. Overall, the digital caliper had better accuracy and precision. 
The digital caliper was used for all of the bloodstain measurements in Study 1. The next 
evaluation was to determine the best approach to measuring the bloodstains, the first option was 
to measure the bloodstain directly using magnification in order to clearly see the margins of the 
bloodstains. For this determination, a fingerprint magnifier was used with the bloodstain on a flat 
surface. The other option was to measure the digital image of the enlarged bloodstain, 
approximately 4X on a computer monitor. The measurements for both approaches utilized the 
digital caliper. Nine different bloodstains were selected for the comparison analysis between 
these two approaches (see Table 8). Table 8 lists the bloodstains from Study 1 that were utilized 
for the evaluation of accuracy and precision. Very low density bloodstain is indicated by 1, and 
the actual sample is the next number; therefore, 1.2 is a bloodstain with very low density and is 
the second of ten bloodstains in this group. The angle indicates the angle of impact for the 
bloodstain, for example 90 degrees. The same nomenclature is used for all of the bloodstains in 
Study 1. Each of the nine bloodstains was measured ten times using each measuring approach for 
a total of ninety determinations for bloodstain measurements with the digital caliper directly on 





measuring off of the enlarged bloodstain image on the computer monitor (see all data on 
comparison of measurements in the Appendix). A summary of the comparison is contained in 
Table 9. The pooled SD for bloodstains measured directly was 0.0159 and the pooled SD for 
enlarged bloodstains was 0.0118. The F statistic was calculated, and it was determined with 95% 
confidence that the difference in SD are due to random error; therefore, measuring directly or 
measuring the enlarged bloodstain are equally precise. It is probable that using a software 
package that would allow for measurements on the computer monitor without the need to utilize 
the digital caliper would significantly increase precision.  
All of the bloodstains for Study 1 were measured (width and length) directly from the 
bloodstains using magnification with the digital caliper to 0.01 mm (see Tables 11, 12, 13, 14, 
and 15 for all bloodstain measurements). Figure 38 shows the digital caliper being used to 
measure the length of a bloodstain. 
Table 7.  Measurements using metal scale and linear caliper for comparison 
 
measurements using scale and linear caliper
target measurement 4.5mm scale - target measurement 120mm scale -
caliper caliper
scale caliper delta scale caliper delta
1 5.25 4.24 1.01 121.0 120.28 0.72
2 5.0 5.18 -0.18 120.5 120.45 0.05
3 5.0 4.41 0.59 120.5 120.65 -0.15
4 5.5 5.06 0.44 120.0 120.41 -0.41
5 5.25 5.18 0.07 120.5 120.16 0.34
6 5.0 5.35 -0.35 120.5 120.53 -0.03
7 5.0 4.59 0.41 120.5 119.87 0.63
8 4.5 4.33 0.17 120.0 120.33 -0.33
9 4.5 4.43 0.07 120.5 120.30 0.20
10 5.0 4.86 0.14 120.0 120.24 -0.24
mean 5.0 4.76 0.34 120.4 120.32 0.31
Sd 0.311 0.410 0.316 0.214
RSD 6.24% 8.62% 0.26% 0.18%
(% error) 11.11% 5.78% 0.33% 0.27%
or
accuracy
The scale is a metal calibrated rule, at low numbers the caliper has a much lower error than the rule 5.78% compared to 11.11%
all measurements were made with the aid of a 5X magnifier and for the rule I could estimate to .25mm, the scale markings were to .5







Figure 38. Linear caliper used to measure bloodstains 
 
 The angle of impact or impact angle was used for all of the bloodstain angle 
determinations in this dissertation. The angles of impact were measured with respect to the plane 
of the surface and were determined from the arc sin of W/L. An alternative approach is to 
determine the angle of incidence, calculated from the arc cosine of W/L. The angle of incidence 
is measured with respect to the normal to the surface, rather than to the surface itself. A drop of 
blood impacting a level surface straight on would have an angle of incidence of 0o and an angle 







Table 8. Bloodstains used for comparison and evaluation of linear caliper 
         
 Bloodstains used for comparison evaluations    
         
         
    90 degrees 55 degrees 10 degrees 
 very low density  1.2  1.4  1.5 
         
 normal density  5.5  5.3  5.1 
         
 very high density  7.1  7.1  7.1 
         
 
Table 9. Average ratios and RSD comparing linear caliper alone to approximately 4X 
enlargement of bloodstain measured with linear caliper. 
        
 average ratios and RSD comparing caliper alone to 4X measurements 
        
 caliper alone   4X measurement  
        
stain 
avg 
ratio  RSD  
avg 
ratio  RSD 
        
10 degrees        
VH  1 0.14  3.59%  0.13  4.94% 
N    2 0.16  4.17%  0.14  8.25% 
VL   3 0.12  4.69%  0.14  4.58% 
        
55 degree        
VH   4 0.81  3.47%  0.79  1.67% 
N     5 0.79  2.23%  0.76  1.58% 
VL   6 0.80  2.70%  0.78  1.95% 
        
90 degree        
VH    7 0.97  1.47%  0.97  1.60% 
N       8 0.98  1.48%  0.98  1.45% 
VL     9 0.98  1.47%  0.98  1.00% 
        






Study 1 Bloodstain Analysis Data  
For each bloodstain (N = 300), the width (W) and length (L) were determined and the 
angle of impact was calculated as W/L = arcsine of angle of impact (MacDonell & Bialousz, 
1971). 
The width, length, W/L, and angle of impact of each bloodstain grouping at each 
predetermined angle are contained in Tables 10 through 14. 
Table 10. Study 1, sample 1 very low density bloodstain measurements. 
 
 
BLOOD SAMPLE #1 (VERY LOW DENSITY)
10 Degrees W L W/L Angle 55 Degrees W L W/L Angle
1.1 6.01 39.44 0.15 8.62 1.1 15.32 17.80 0.86 59.31
1.2 5.44 41.02 0.13 7.46 1.2 15.14 18.37 0.82 55.08
1.3 5.50 34.10 0.16 9.20 1.3 14.93 18.73 0.80 53.13
1.4 5.37 37.70 0.14 8.04 1.4 13.79 17.38 0.79 52.18
1.5 4.69 40.24 0.12 6.89 1.5 13.85 18.16 0.76 49.46
1.6 5.96 42.42 0.14 8.04 1.6 13.51 17.33 0.78 51.26
1.7 5.43 32.54 0.17 9.78 1.7 13.43 18.06 0.74 47.73
1.8 5.31 33.63 0.16 9.20 1.8 13.76 17.57 0.78 51.26
1.9 4.77 36.45 0.13 7.46 1.9 15.30 18.77 0.82 55.08
1.10 5.32 36.64 0.15 8.62 1.10 13.62 17.55 0.78 51.26
mean 5.38 37.42 8.33 mean 14.27 17.97 52.57
SD 0.40 3.17 0.92 SD 0.75 0.50 3.27
25 Degrees 70 Degrees
1.1 11.53 33.87 0.34 19.87 1.1 19.00 20.23 0.94 70.05
1.2 10.27 24.91 0.41 24.20 1.2 15.83 17.65 0.90 64.15
1.3 8.82 24.26 0.36 21.10 1.3 13.98 16.45 0.85 58.21
1.4 8.76 31.81 0.28 16.26 1.4 14.37 16.15 0.89 62.87
1.5 * 1.5 14.70 16.20 0.91 65.50
1.6 9.41 26.90 0.35 20.48 1.6 14.17 15.98 0.89 62.87
1.7 9.94 30.25 0.33 19.26 1.7 16.35 17.80 0.92 66.92
1.8 * 1.8 16.81 18.10 0.93 68.43
1.9 9.84 28.74 0.34 19.87 1.9 15.82 16.92 0.93 68.43
1.10 9.25 28.76 0.32 18.66 1.10 14.81 17.11 0.87 60.45
mean 9.73 28.69 19.96 mean 15.58 17.26 64.78
SD 0.84 3.08 2.24 SD 1.45 1.21 3.78
40 Degrees 90 Degrees
1.1 14.25 23.96 0.59 36.15 1.1 17.36 17.68 0.98 78.52
1.2 14.90 25.09 0.59 36.15 1.2 17.74 17.84 0.99 81.89
1.3 15.15 25.33 0.60 36.86 1.3 17.78 18.77 0.95 71.80
1.4 15.26 25.18 0.61 37.58 1.4 18.21 18.51 0.98 78.52
1.5 14.20 23.55 0.60 36.86 1.5 17.41 18.40 0.95 71.80
1.6 14.51 24.19 0.60 36.86 1.6 17.95 18.47 0.97 75.93
1.7 16.27 25.07 0.65 40.54 1.7 17.46 18.16 0.96 73.73
1.8 14.50 22.38 0.65 40.54 1.8 17.93 18.21 0.98 78.52
1.9 14.84 23.55 0.63 39.05 1.9 16.38 17.04 0.96 73.73
1.10 15.09 23.64 0.64 39.79 1.10 16.64 17.88 0.93 68.43
mean 14.90 24.19 38.03 mean 17.49 18.10 75.28
SD 0.57 0.91 1.76 SD 0.55 0.47 4.10















BLOOD SAMPLE #3 (LOW DENSITY)
10 Degrees W L W/L Angle 55 Degrees W L W/L Angle
3.1 5.86 36.44 0.16 9.20 3.1 15.76 19.56 0.81 54.09
3.2 7.29 34.10 0.21 12.12 3.2 14.39 18.98 0.76 49.46
3.3 7.35 40.33 0.18 10.36 3.3 14.08 18.59 0.76 49.46
3.4 6.02 42.13 0.14 8.04 3.4 15.26 18.18 0.84 57.14
3.5 6.57 44.54 0.15 8.62 3.5 15.41 18.93 0.81 54.09
3.6 7.55 36.73 0.21 12.12 3.6 14.91 19.23 0.78 51.26
3.7 7.13 37.19 0.19 10.95 3.7 15.50 18.86 0.82 55.08
3.8 7.37 41.87 0.18 10.36 3.8 13.53 17.38 0.78 51.26
3.9 6.47 45.11 0.14 8.04 3.9 14.37 18.08 0.79 52.18
3.10 6.86 42.04 0.16 9.20 3.10 13.94 17.62 0.79 52.18
mean 6.85 40.05 9.91 mean 14.72 18.54 52.62
SD 0.56 3.53 1.52 SD 0.71 0.67 2.46
25 Degrees 70 Degrees
3.1 11.59 28.22 0.41 24.20 3.1 15.11 16.19 0.93 68.43
3.2 12.24 32.47 0.38 22.33 3.2 16.55 17.56 0.94 70.05
3.3 12.00 28.14 0.43 25.46 3.3 14.28 15.71 0.91 65.50
3.4 11.74 25.14 0.47 28.03 3.4 14.52 15.87 0.91 65.50
3.5 * 3.5 15.63 17.14 0.91 65.50
3.6 9.97 27.70 0.36 21.10 3.6 16.65 17.72 0.94 70.05
3.7 10.12 27.96 0.36 21.10 3.7 15.66 17.26 0.91 65.50
3.8 11.11 26.02 0.43 25.46 3.8 14.87 16.79 0.89 62.87
3.9 11.06 25.94 0.43 25.46 3.9 15.22 16.46 0.92 66.92
3.10 10.08 26.52 0.38 22.33 3.10 15.91 16.90 0.94 70.05
mean 11.1 27.57 23.94 mean 15.44 16.76 67.03
SD 0.81 2.02 2.37 SD 0.75 0.65 2.49
40 Degrees 90 Degrees
3.1 12.55 18.58 0.68 42.84 3.1 16.18 16.77 0.96 73.73
3.2 13.66 19.70 0.69 43.63 3.2 15.13 15.24 0.99 81.89
3.3 13.93 20.64 0.67 42.06 3.3 14.99 15.64 0.96 73.73
3.4 13.05 20.09 0.65 40.54 3.4 15.39 15.96 0.96 73.73
3.5 13.73 17.42 0.79 52.18 3.5 16.02 16.17 0.99 81.89
3.6 15.03 19.00 0.79 52.18 3.6 *
3.7 13.28 20.64 0.64 39.79 3.7 15.89 16.12 0.99 81.89
3.8 11.91 17.69 0.67 42.06 3.8 15.55 15.94 0.98 78.52
3.9 12.44 19.99 0.62 38.31 3.9 15.46 15.55 0.99 81.89
3.10 13.44 20.34 0.66 41.29 3.10 15.61 15.57 1.00 90.00
mean 13.3 19.41 43.48 mean 15.58 15.88 79.69
SD 0.83 1.12 4.82 SD 0.37 0.42 5.40















BLOOD SAMPLE #5 (NORMAL DENSITY)
10 Degrees W L W/L Angle 55 Degrees W L W/L Angle
5.1 5.41 31.45 0.17 9.78 5.1 15.24 19.62 0.78 51.26
5.2 5.91 39.39 0.15 8.62 5.2 14.95 19.56 0.76 49.46
5.3 5.15 34.87 0.15 8.62 5.3 14.80 19.39 0.76 49.46
5.4 5.03 39.73 0.13 7.46 5.4 15.60 19.13 0.82 55.08
5.5 6.14 33.64 0.18 10.36 5.5 13.96 18.18 0.77 50.35
5.6 5.06 37.49 0.13 7.46 5.6 13.85 18.40 0.75 48.59
5.7 5.40 31.18 0.17 9.78 5.7 15.44 20.02 0.77 50.35
5.8 5.75 39.33 0.15 8.62 5.8 15.06 19.12 0.79 52.18
5.9 5.81 40.03 0.15 8.62 5.9 15.54 19.53 0.80 53.13
5.10 5.32 37.48 0.14 8.04 5.10 15.02 19.02 0.79 52.18
mean 5.50 36.46 8.73 mean 14.95 19.20 51.21
SD 0.36 3.25 0.97 SD 0.57 0.53 1.97
25 Degrees 70 Degrees
5.1 9.53 25.12 0.38 22.33 5.1 16.62 17.61 0.94 70.05
5.2 8.47 29.75 0.28 16.26 5.2 17.29 18.80 0.92 66.92
5.3 9.55 28.40 0.34 19.87 5.3 13.42 15.16 0.89 62.87
5.4 9.08 29.28 0.31 18.05 5.4 16.49 17.58 0.94 70.05
5.5 9.88 30.08 0.33 19.26 5.5 16.14 17.38 0.93 68.43
5.6 8.92 33.46 0.27 15.66 5.6 16.32 17.39 0.94 70.05
5.7 8.76 25.62 0.34 19.87 5.7 17.35 18.48 0.94 70.05
5.8 9.13 29.14 0.31 18.05 5.8 15.99 17.69 0.90 64.15
5.9 9.47 26.65 0.36 21.10 5.9 15.60 17.01 0.92 66.92
5.10 8.92 28.01 0.32 18.66 5.10 15.67 17.64 0.89 62.87
mean 9.17 28.55 18.91 mean 16.09 17.47 67.23
SD 0.40 2.30 2.04 SD 1.05 0.91 2.99
40 Degrees 90 Degrees
5.1 13.50 21.22 0.64 39.79 5.1 15.63 15.61 1.00 90.00
5.2 13.00 20.72 0.63 39.05 5.2 16.40 17.05 0.96 73.73
5.3 12.61 20.33 0.62 38.31 5.3 14.76 15.31 0.96 73.73
5.4 12.42 20.63 0.60 36.86 5.4 17.57 17.49 1.00 90.00
5.5 12.64 20.29 0.62 38.31 5.5 16.14 16.27 0.99 81.89
5.6 13.20 21.87 0.60 36.86 5.6 16.21 16.63 0.97 75.93
5.7 13.73 21.48 0.64 39.79 5.7 16.07 16.91 0.95 71.80
5.8 13.19 20.65 0.64 39.79 5.8 16.37 16.59 0.99 81.89
5.9 13.15 20.04 0.66 41.29 5.9 16.61 16.53 1.00 90.00
5.10 12.00 19.07 0.63 39.05 5.10 15.60 15.65 1.00 90.00
mean 12.94 20.63 38.91 mean 16.14 16.40 81.89















BLOOD SAMPLE #6 (HIGH DENSITY)
10 Degrees W L W/L Angle 55 Degrees W L W/L Angle
6.1 4.28 28.24 0.15 8.62 6.1 12.29 13.63 0.90 64.15
6.2 4.35 24.49 0.18 10.36 6.2 10.77 13.77 0.78 51.26
6.3 4.76 28.80 0.17 9.78 6.3 10.41 13.32 0.78 51.26
6.4 4.75 25.62 0.19 10.95 6.4 11.21 14.07 0.80 53.13
6.5 5.02 29.95 0.17 9.78 6.5 *
6.6 4.11 33.57 0.12 6.89 6.6 11.80 14.38 0.82 55.08
6.7 4.77 30.71 0.16 9.20 6.7 10.77 13.10 0.82 55.08
6.8 5.36 29.32 0.18 10.36 6.8 10.82 13.63 0.79 52.18
6.9 5.29 26.66 0.20 11.53 6.9 9.58 13.07 0.73 46.88
6.10 * 6.10 10.45 13.42 0.78 51.26
mean 4.27 25.74 9.71 mean 10.90 13.60 53.36
SD 0.41 2.60 1.37 SD 0.75 0.40 4.73
25 Degrees 70 Degrees
6.1 8.10 19.42 0.42 24.83 6.1 10.84 13.71 0.79 52.18
6.2 7.82 19.50 0.40 23.57 6.2 10.76 11.91 0.90 64.15
6.3 8.02 18.78 0.43 25.46 6.3 9.24 11.99 0.77 50.35
6.4 8.04 18.93 0.42 24.83 6.4 11.56 12.52 0.92 66.92
6.5 * 6.5 *
6.6 6.92 17.56 0.39 22.95 6.6 11.96 13.99 0.85 58.21
6.7 7.32 19.04 0.38 22.33 6.7 11.89 14.94 0.80 53.13
6.8 7.55 18.74 0.40 23.57 6.8 11.83 13.03 0.91 65.50
6.9 6.93 17.17 0.40 23.57 6.9 11.40 12.23 0.93 68.43
6.10 7.33 18.29 0.40 23.57 6.10 11.91 12.55 0.95 71.80
mean 7.56 18.60 23.85 mean 11.27 12.99 61.18
SD 0.43 0.74 0.99 SD 0.83 0.97 7.88
40 Degrees 90 Degrees
6.1 9.96 14.65 0.68 42.84 6.1 12.22 12.65 0.97 75.93
6.2 10.45 12.83 0.81 54.09 6.2 12.20 12.53 0.97 75.93
6.3 9.54 14.56 0.64 39.79 6.3 12.38 12.33 1.00 90.00
6.4 9.94 16.18 0.61 37.58 6.4 *
6.5 * 6.5 10.07 10.40 0.97 75.93
6.6 10.07 14.84 0.68 42.84 6.6 12.35 12.74 0.97 75.93
6.7 9.53 15.97 0.60 36.86 6.7 10.92 11.23 0.97 75.93
6.8 10.68 16.74 0.64 39.79 6.8 9.34 10.04 0.93 68.43
6.9 10.87 16.63 0.65 40.54 6.9 11.63 12.26 0.95 71.80
6.10 10.55 16.14 0.65 40.54 6.10 11.80 12.03 0.98 78.52
mean 10.18 15.39 42.25 mean 11.43 11.80 76.48
SD 0.45 1.20 5.08 SD 1.03 0.94 5.86















BLOOD SAMPLE #7 (VERY  HIGH DENSITY)
10 Degrees W L W/L Angle 55 Degrees W L W/L Angle
7.1 4.45 29.70 0.15 8.62 7.1 11.71 14.20 0.82 55.08
7.2* 7.4A 6.38 33.87 0.19 10.95 7.2 10.99 13.40 0.82 55.08
7.3 5.26 30.15 0.17 9.78 7.3 11.17 13.98 0.80 53.13
7.4 5.24 33.02 0.16 9.20 7.4 11.09 13.02 0.85 58.21
7.5 5.93 32.74 0.18 10.36 7.5 11.08 12.54 0.88 61.64
7.6 5.61 27.48 0.20 11.53 7.6 11.26 13.48 0.84 57.14
7.7 5.74 30.90 0.19 10.95 7.7 10.72 13.46 0.80 53.13
7.8 5.57 33.83 0.16 9.20 7.8 11.56 13.09 0.88 61.64
7.9 5.62 29.05 0.19 10.95 7.9 11.35 13.91 0.82 55.08
7.10 5.44 28.89 0.19 10.95 7.10 10.81 13.33 0.81 54.09
mean 5.52 30.96 10.24 mean 11.17 13.44 56.42
SD 0.47 2.15 0.98 SD 0.29 0.47 3.17
25 Degrees 70 Degrees
7.1 8.16 19.60 0.42 24.83 7.1 12.50 13.48 0.93 68.43
7.2 7.94 18.78 0.42 24.83 7.2 *
7.3 7.63 19.89 0.38 22.33 7.3 12.09 13.32 0.91 65.50
7.4 8.44 20.87 0.40 23.57 7.4 12.18 13.48 0.90 64.15
7.5 7.87 20.22 0.39 22.95 7.5 10.82 12.42 0.87 60.45
7.6 8.23 19.44 0.42 24.83 7.6 10.41 12.05 0.86 59.31
7.7 8.71 20.77 0.42 24.83 7.7 12.65 13.41 0.94 70.05
7.8 7.89 20.28 0.39 22.95 7.8 *
7.9 7.99 20.70 0.39 22.95 7.9 12.25 13.76 0.89 62.87
7.10 8.04 18.80 0.43 25.46 7.10 11.02 12.33 0.89 62.87
mean 8.09 19.94 23.95 mean 11.74 13.03 64.21
SD 0.29 0.73 1.11 SD 0.79 0.61 3.69
40 Degrees 90 Degrees
7.1 10.32 17.40 0.59 36.15 7.1 13.82 13.84 1.00 90.00
7.2 10.85 17.67 0.61 37.58 7.2 12.90 12.63 1.02 90.00
7.3 10.67 17.03 0.63 39.05 7.3 12.56 13.20 0.95 71.80
7.4 10.13 15.65 0.65 40.54 7.4 12.80 12.77 1.00 90.00
7.5 9.74 15.85 0.61 37.58 7.5 12.54 12.78 0.98 78.52
7.6 9.69 15.12 0.64 39.79 7.6 13.43 13.37 1.00 90.00
7.7 9.79 15.79 0.62 38.31 7.7 11.60 12.17 0.95 71.80
7.8 10.24 16.78 0.61 37.58 7.8 11.16 11.49 0.97 75.93
7.9 10.91 17.76 0.61 37.58 7.9 11.25 11.56 0.97 75.93
7.10 9.24 15.25 0.61 37.58 7.10 11.50 11.84 0.97 75.93
mean 10.16 16.43 38.17 mean 12.35 12.56 80.99
SD 0.52 0.95 1.28 SD 0.88 0.74 8.00
* bloodstain geometry not clear





Data Analysis Approach 
For Studies 1, 2, and 3, the hypotheses were tested by the computation and examination 
of 95% CIs (CI) as described by Kock (2015) and by the interpretation of effect sizes, as 
recommended by Ferguson (2009) and Sullivan & Feinn (2012). The statistical analysis was 
conducted with Minitab v. 17.3 software (Minitab Inc., State College, PA), using the protocols 
described by Peck et al. (2016). 
Interval plot with mean ± 95%  confidence interval (CI)  
Interval plots (otherwise known as error bar charts) were constructed using Minitab 17.3 
software to provide graphical summaries that visually compared the mean values of a numerical 
variable sampled from a known population of data (e.g., the angle of impact and the location of 
the volume of origin of the blood spatter) classified into specified groups (e.g., five levels of 
blood density). The mean value of each group of data was represented by a circular symbol. The 
95% CI of each mean value was symbolized by a vertical bar (Hampton & Havel, 2014; Minitab, 
2016; Peck et al., 2016).   
The 95% CI encompasses the range of values that should theoretically contain the true 
mean value of the population of data in 95 out of 100 samples (assuming that a representative 
sample has been drawn from the population). The researcher can be 95% confident that the true 
mean value of the data in a specified group is captured within the lower and upper limit of the CI 
for that group. The difference between values of two group means is probably significant (at the 
p = 0.05 level of statistical significance) when the interval bars do not overlap with each other 
(Kock, 2015).  
The 95% CI not only provides information on the variability of the mean value in an 





probable relationship of the sample mean to the true value of the mean in the population from 
which the sample was drawn (i.e., the accuracy of the mean). A CI calculated to measure the 
effects of a treatment indicates the range within which the true effect of the treatment is likely to 
be captured. CIs aid the interpretation of experimental data by putting upper and lower limits on 
the likely size of any true effect of a treatment (Davies & Crombie, 2009).  
The formula to calculate a 95% CI is: 
M ± t (N–1) × SE 
where M = mean value of a sample of data; t (N–1).is the critical value of the t statistic at p = 0.05 
when the sample size is N; and SE is the standard error of the mean, given by σ/√N, (where σ = 
standard deviation of the sample of data).  
Research Questions and Research Hypotheses 
The purpose of Study 1 was to analyze the statistical relationship between blood density, 
angle of impact, and the geometry of the bloodstains.  
The four research questions are: 
 RQ1a: To what extent is blood density correlated with the geometry (i.e., width and length) 
of the bloodstain? 
 RQ1b: To what extent is blood density correlated with the pre-defined angle of impact? 
 RQ1c: To what extent does the pre-defined angle of impact act as a mediator in the 
correlation between blood density and the geometry of the bloodstain? 
 RQ1d: To what extent is there a difference between the pre-defined angles of impact and the 
calculated angles of impact? 
The four associated research hypotheses are: 





 H1b: The angle of impact is correlated with the geometry of the bloodstain. 
 H1c: The angle of impact acts as a moderator, altering the strength and/or direction of the 
correlation between blood density and the geometry of the bloodstain. 
 H1d: There is no difference between the pre-defined angles of impact and the calculated 
angles of impact of the bloodstains (Fisher, R., personal communication 4/30/ 2018). 
Data Analysis 
Moderation analysis.  
The generic moderation model to test H1a to H1c is illustrated in Figure 39, where the 
rectangular symbols represent the variables, and the arrows represent the correlations between 
the variables. The interaction term to identify the moderating effect is the product of the 
predictor x the moderator. 
 
Figure 39. Generic moderator model (adapted from Baron & Kenny, 1986). 
The testing of H1a to H1c assumed that a moderator (i.e., the pre-defined angle of 





(i.e., the blood density) and the outcome variable (i.e., the geometry of the bloodstain). 
Moderation meant that the correlation between blood density and the geometry of the bloodstain 
was not consistent with respect to all angles of incidence. The correlation between blood density 
and the geometry of the bloodstain might be weak at certain angles of impact, but the correlation 
may be strong at other angles of impact. 
Hypotheses involving the evaluation of moderating effects have, for over 30 years, been 
tested by regression analysis based on the computation or ordinary least squares (OLS) (Baron & 
Kenny, 1986; Hayes, 2013). However, in the last decade, more modern techniques, including 
moderated path analysis, based on the computation of partial least squares (PLS) have been 
developed (Aimram et al., 2015; Edwards & Lambert, 2007; Fassot et al., 2016; Wong, 2016). 
Figure 40 illustrates the path diagram to test H1a, H1b, and H1c using moderated path analysis. 
The oval symbols represent the variables, and the arrows represent the hypotheses, proposing 
correlations between the variables. The interaction term to identify the moderating effect is angle 
of impact x blood density. 
 






The advantages of using PLS path analysis over OLS regression as discussed by Hair et 
al. (2017) are as follows:  
 PLS is a non-parametric method, therefore, unlike OLS regression, it does not assume that 
the variables are normally distributed;  
 unlike OLS regression, PLS operates with variables having all types of measurement and 
distributional characteristics (e.g., nominal, ordinal, and interval level);  and 
 unlike OLS regression, PLS achieves a high level of statistical power with small sample sizes 
because the correlations (path coefficients) between the variables and the statistical 
significance of the path coefficients are computed by bootstrapping.  
The bootstrapping procedure samples and resamples the data to collect a total of 5000 
random sub samples. The Monte Carlo algorithm for subsampling is used for the bootstrap, 
meaning that the data are shuffled like a pack of cards in a casino before each sub-sample is 
drawn from the data set. The bootstrapped mean, standard error, and 95% CI for each path 
coefficient are computed. H1a, H1b, and H1c are supported if:  
 the 95% CIs of the path coefficients do not include zero; and  
 the effect size, indicated by R2 = the proportion of the variance explained, is large enough to 
reflect practical significance. The criterion of Ferguson (2009) was applied that the absolute 
minimum effect size to indicate a practically significant effect is R2 = 0.04 (i.e., 4% of the 
variance is explained).  
The limitation of using PLS path analysis to examine moderation is that the magnitude 
and significance of the path coefficient between the moderating effect (i.e., blood density x the 
geometry of the bloodstain) and the dependent variable (i.e., geometry of bloodstain) symbolized 





2013). A graphical analysis was therefore conducted to provide a visual method of examining 
how the correlation between the blood density and the width and length of the blood stain 
changed in strength and/or direction with respect to different levels of the pre-defined angle of 
impact. Linear trend lines were fitted to the scatterplots of the geometry of the bloodstain and the 
blood density. Moderating effects were visualized by the slopes of the fitted linear trend lines 
changing systematically across the six pre-defined angles of impact (i.e., 10, 25, 40, 55, 70, and 
90o). 
H1d, proposing no difference between the pre-defined angles of impact and the computed 
angles of impact (derived from the width divided by the length of the bloodstain), was tested by 
determining if the pre-defined angles of impact (i.e., 10, 25, 40, 55, 70, and 90o) were captured 
within the lower and upper limits of the 95% CI of the computed angles of impact. 
This section provides the results of moderation analysis to address the research questions 
RQ1a, RQ1b, and RQ1c and test the associated hypotheses H1a, H1b, and H1c. Figure 41 
presents the path diagram output by SmartPLS® (SmartPLS GmbH, Hamburg, Germany) to 
illustrate the relationships between the blood density (predictor), the pre-defined angle of impact 
(moderator), the width of the bloodstain (outcome), and the moderating effect (blood density x 
angle of impact) when the blood density was increased using an ordinal scale ranging from very 
low (1) to very high (7). The R2 value = 0.769 (i.e., 76.9% of the variance in the width of 
bloodstain was explained) was well above the minimum effect size of 0.04 required to reflect a 









Figure 41. Path analysis of the moderating effect of angle of impact on the correlation between 
blood density and width of bloodstain.  
The negative path coefficient between the blood density and the width of bloodstain (β = 
-0.342, 95% CI = -0.311, -0.373) was less than zero. Consequently, when the blood density 
increased, the width of bloodstain decreased. The path coefficient between the angle of impact 
and the width of bloodstain (β = 0.792, 95% CI = 0.768, 0.815) was significantly greater than 
zero (because the positive 95% CI did not capture zero). Consequently, when the angle of impact 
increased, the width of bloodstain also increased. Figure 42 illustrates the positive correlation 







Figure 42. Correlation between angle of impact and width of bloodstain.  
 
The path coefficient for the moderating effect (blood density x angle of impact) (β = -
0.129, 95% CI = -0.096, -0.162) was significantly less than zero. Consequently, the angle of 
impact was identified as a significant moderator, and the moderating effect was negative. 
Figure 43 illustrates the negative moderating effect of angle of impact on the linear 
correlation between the width of bloodstain and blood density. When the angle of impact was 
10o, the linear trend line fitted to the data was almost horizontal, reflecting little or no correlation 
between blood density and width of bloodstain. However, when the angle of impact was 
increased progressively to 25, 40, 55, and 70o, the downward sloping fitted linear trend lines 
became progressively steeper. The steepest linear trend line was when the angle of impact = 90o. 





of bloodstain when the blood density was increased from very low (1), through low (3), normal 
(5), and high (6) to very high (7). 
 
 
Figure 43.Visual analysis of the moderating effect of angle of impact on the correlation between 
blood density and width of bloodstain. 
 
Figure 44 presents the path diagram output by SmartPLS to illustrate the relationships 
between the blood density (predictor) the pre-defined angle of impact (moderator), the length of 
the bloodstain (outcome), and the moderating effect (blood density x angle of impact). The R2 
value = 0.722 (72.2% of the variance in the length of bloodstain was explained) was well above 









Figure 44. Path analysis of the moderating effect of angle of impact on the correlation between 
blood density and length of bloodstain.  
 
The negative path coefficient between the blood density and the length of Bloodstain (β = 
-0.455, 95% CI = -0.389, -0.520) was significantly less than zero. Consequently, when the blood 
density increased, the length of bloodstain decreased. The negative path coefficient between the 
angle of impact and the length of bloodstain (β = -0.953, 95% CI = -0.897, -1.008) was 
significantly less than zero (because the negative 95% CI did not capture zero). Consequently, 
when the angle of impact increased, the length of bloodstain decreased. Figure 45 illustrates the 
negative correlation between the angle of impact and the length of bloodstain using a fitted linear 







Figure 45. Correlation between angle of impact and length of bloodstain. 
 
The path coefficient for the moderating effect (β = 0.299, 95% CI = 0.181, 0.417) was 
significantly greater than zero. Consequently, the angle of impact was identified as a moderator 
and the moderating effect was positive. Figure 46 illustrates the effect of angle of impact on the 
linear correlation between the length of bloodstain and blood density. When the angle of impact 
was 10 degrees, the linear trend line fitted to the data sloped downward, reflecting the negative 
correlation between blood density and length of bloodstain. When the angle of impact was 
increased progressively to 25, 40, 55, and 70o, the fitted linear trend lines tended to be less steep. 
The linear trend line with the lowest slope occurred when the angle of impact was 90o.  
Consequently, there was a systematic moderating effect of angle of impact on the length of 






Figure 46. Visual analysis of the moderating effect of angle of impact on the correlation between 
blood density and length of bloodstain. 
 
The summarized results of the testing of hypotheses H1a, H1b, and H1c, based on the 
moderation analysis presented above, are that:  
 H1a: Blood density is correlated with the width and the length of the bloodstain;  
 H1b: The angle of impact is correlated with the geometry (i.e., the width and length) of the 
bloodstain, and  
 H1c: The angle of impact acted as a moderator, by altering the strength and/or direction of 
the correlation between the blood density and the width and length of the bloodstain. 
 Hid: there is no difference between the pre-defined angles of impact and the calculated 
angles of impact was tested by comparing the pre-defined angles of impact (i.e. 10, 25, 40, 





impact. Figures 47–52 present the results. The mean calculated angles of impact are 
represented by circular symbols and the lower and upper bounds of the 95% CI are 
represented by I symbols. Differences between the pre-defined and calculated angles were 
indicated if the pre-defined angles did not strongly overlap with the lower and upper 
boundaries of the 95% CI of the calculated angles. Figure 47 shows that when the blood 
density was very low (1) and normal (5) the mean calculated angles (8.33 and 8.74 degrees) 
were lower than the pre-defined angle (10 degrees). Figure 48 shows that the mean calculated 
angles (18.94 and 23.95 degrees) were consistently lower than the pre-determined angle (25 
degrees) at all levels of blood density. Figure 49 shows that when the blood density was very 
low (1), normal (5), and very high (7) the mean calculated angles (38.04, 36.87 and 38.17 
degrees) were lower than the pre-defined angle (40 degrees). Figure 50 shows that the mean 
calculated angles (52.58 to 53.36 degrees) were consistently lower than the pre-determined 
angle (55 degrees) when the blood density was very low (1), low (3), normal (5), and high 
(6), but greater than the 55 degrees  (56.42 degrees) when the blood density was very high 
(7). Figure 51 shows that the mean calculated angles (61.19 to 67.24 degrees) were 
consistently lower than the pre-determined angle (70 degrees) at all levels of blood density. 
Figure 52 also shows that the mean calculated angles (75.29 to 81.89 degrees) were 









Figure 47. Comparison of pre-defined angle of impact (10o) vs. mean and 95% CI of calculated 
angles of impact. Mean calculated angles of impact are represented by circular symbols and the 












Figure 48. Comparison of pre-defined angle of incidence (25o) vs. mean and 95% CI of 
calculated angles of impact. Mean calculated angles of impact are represented by circular 








Figure 49. Comparison of pre-defined angle of impact (40o) vs. mean and 95% CI of calculated 
angles of impact. Mean calculated angles of impact are represented by circular symbols and the 








Figure 50. Comparison of pre-defined angle of impact (55o) vs. mean and 95% CI of calculated 
angles of impact. Mean calculated angles of impact are represented by circular symbols and the 







Figure 51. Comparison of pre-defined angle of impact (70o) vs. mean and 95% CI of calculated 
angles of impact. Mean calculated angles of impact are represented by circular symbols and the 







Figure 52. Comparison of pre-defined angle of impact (90o) vs. mean and 95% CI of calculated 
angles of impact. Mean calculated angles of impact are represented by circular symbols and the 
lower and upper bounds of the 95% CI are represented by I symbols. 
 
The hypothesis H1d was rejected. When the pre-defined angles of impact were higher (55 
to 90 degrees), then the calculated angles of impact at all levels of blood density were lower than 
the pre-defined angles. At lower pre-defined angles of impact, there appeared to be no systematic 
effects of blood density on the differences between the pre-determined and calculated angles of 
impact. 
Conclusions 
Blood density is correlated with the width and the length of the bloodstains. The angle of 
impact is correlated with the geometry (W and L) of the bloodstain. The angle of impact acts as a 





the width and length of the bloodstain. The moderating effect was negative for the width and 
positive for the length of the bloodstain. The result is that the change in density of the blood does 
not alter the angle of impact but does have an effect on other characteristics of the bloodstain.  
The bloodstains produced by the low density blood were either very light red or light red 
in color and had multiple tails. This seems to indicate that there are multiple breaks in the surface 
tension upon striking a surface as compared to a bloodstain with a single tail. High density 
samples were dark red in color with a single shorter tail as compared to normal density 
bloodstains. The difference in color and geometry do not effect the angle of impact 
determinations as the tail portion of the bloodstain is not used in calculations (Fisher, R, personal 
communication 5/3/18). 
 
Chapter 3. Study 2: Impact – Area of Origin Determination 
Purpose and Study Plan 
The purpose of Study 2 was to conduct simulations to compare the known area of origin 
(intersection, convergence) of bloodstains to the calculated areas of origin of bloodstains using a 
manual string approach and a commercially available computer program (HemoSpat®) with five 
blood samples of varying densities. Five simulations for each blood sample provided 25 










Construction of Device to Simulate Blood Spatter 
To complete Study 2, a device had to be fabricated that could be used to generate the 
blood spatter for all of the simulations and a room had to be constructed to carry out the blood 
spatter study. 
Device construction.  
A device was fabricated which would have the ability to generate blood spatter on the 
walls of the simulation room. A Rawlings R 25 inch, 12 oz metal alloy bat (Rawlings Sporting 
Goods, St. Louis, MO) was chosen as the “weapon” that would be used to strike a target. Metal 
was chosen over a wooden bat as it was easier to clean the metal bat between simulations. The 
device to hold the bat and allow it to rotate on its axis was constructed from perforated metal 
sections bolted to an acrylic base. A hole was drilled through the base of the bat allowing a 
threaded metal rod to pass through it and act as the axis for rotation of the bat. The bat was 25 
inches in length. The testing of the bat falling under its own weight onto a target saturated with 
synthetic blood (Arrowhead Forensics, Lenexa, KS) failed to produce adequate blood spatter. A 
1-lb weight was attached to the bat to determine if the additional weight would resolve this 
situation, but it was not effective. It was decided to add two Everbilt 5/8 inch x 6½ inch extension 
springs to increase the rate of motion of the bat towards the target and produce a uniform impact. 
Figure 38 depicts springs and with added weight in place. The device allows the bat to rotate 










Figure 53. Close up of the blood spatter device and ballistic gel. Arrows left to right show: end 
of bat striking ballistic gel target, extra weights, springs and bat shaft with rotation rod. 
 
A 10% ballistic gelatin block from Clear Ballistics (Clear Ballistics LLC, Fort Smith, 
AR) was used as the target in order to simulate the bat striking an individual. The ballistic block 
measured 22.5 cm in length, 10 cm in width, and 10 cm in depth. A variety of items were 
evaluated for holding a fixed amount of blood in place on the ballistic gel for the bat to strike. 
These items included the following: 
1. Studio 35 Beauty latex free cosmetic wedges, measuring 4.2 cm x 2.4 cm with the depth 
varying from 1.5 cm to 0.4 cm. 
2. Studio 35 Beauty textured cotton rounds, measuring 5.5 cm in diameter, with a depth of 0.2 





3. Studio 35 Beauty quilted cotton squares, measuring 5.8 cm x 5.2 cm x 0.3 cm. This item was 
tested with a single square, 2 squares together, and 3 squares together. 
4. 3M Ocelo sponge, a section of the sponge was cut out measuring 3 cm x 4 cm x 1.8 cm. See 
Figure 54S. 
 
Figure 54. Materials tested to hold blood samples for blood spatter simulations. 
 
All of the above initial evaluation testing was conducted using synthetic blood obtained 
from Arrowhead Forensics. Synthetic blood is a proprietary dilute aqueous mixture containing 
hemoglobin, amino acids, protein, and other components (MSDSs in the Appendix). 
Each of the 4 materials listed above had a total of 1 mL (20 drops from a VWR 
disposable glass Pasteur pipet) dropped onto it. 
All of the initial testing of the device was conducted in an empty farm house (Figure 55) 
with permission of the owner. This farm house, which is located in a remote area, was later used 
for Study 3 ballistics testing. Since, the farm house had no electricity experiments were limited 





All of the subsequent testing was conducted in either a room built for this purpose or at the farm 
house but with the use of a generator to power lights and a water bath. 
 
Figure 55. Farm house for preliminary testing of Study 2. 
 
Each of the 4 materials was evaluated, and none provided a sufficient number of 
bloodstains for analysis, which were at least 10 bloodstains with a suitable geometry for angle of 
impact determination. The final evaluation was to cut out a section of the ballistic gel that was 
suitable for holding 1 mL of blood and not using any absorbent material to hold the blood. The 
section that was cut out measured 2.5 cm x 2.0 cm x 0.2 cm. This simulated what would be the 
second strike to the head (exposed skin area) of an individual as blood was already on the surface 
of the skin as a result of the first strike. This approach was successful in generating a sufficient 
number of bloodstains to allow for utilization of the string method and the computer generated 





ballistic gel was evaluated for use as a target, but problems with keeping a blood sample of 
constant volume in place to conduct the simulations was unfortunately not feasible. See Figures 
58 and 59.  
 
Figure 56. Ballistic gel target with cut out for blood samples. 
 
 







Figure 58. Ballistic gel head as possible target.  
       
 





Room Construction for Blood Spatter Simulations 
The next phase required the building of a room in which to carry out the simulations. The 
room was constructed from Charlotte Pipe (Charlotte Pipe, Charlotte, NC) 1 inch PVC piping 
and wall board material that had a smooth surface. The surface was easily cleaned between 
simulations and the smooth surface allowed for bloodstains with clear geometry without surface-
induced distortions. The room measured as follows: height 209 cm, width 214 cm, and length 
240 cm. See Figures 60-62 for completed room for simulations.   
 







Figure 61. Room construction for blood spatter simulations. 
 
 






Once the room construction was completed, the first testing of the device in the 
simulation room was with synthetic blood at 37 oC. This was followed with the simulations 
utilizing the five blood samples of varying densities. 
Preparation of Blood Samples 
Human blood components were purchased from BioIVT and consisted of the following: 
 100 mL of human whole blood with sodium heparin added as anticoagulant, 
 75 mL of human red blood cells with sodium heparin added as an anticoagulant, and 
 100 mL of unfiltered human serum. 
All of the human blood components were tested and found to be negative for the 
following: HIV 1/2 Ab, HCV Ab (hepatitis C), non-reactive for HBsAg (hepatitis B), HIV-1 
RNA, HCV RNA (hepatitis C), HBV DNA, WNV RNA, ANTI-T CRUZI, and STS (syphilis) 
(certificates of analysis are contained in the Appendix).The blood samples were prepared as 
described in Table 15, and the density and HCT were determined for each (Tables 16-17). 
 
Table 15. Preparation matrix for the blood samples 
Sample Number Serum, % Serum, mL Cells, % Cells, mL 
1 95 38 5 2 
2 85 34 15 6 
3 60 24 40 16 
4 20 8 80 32 







Table 16. Sample density determinations 







Table 17. Sample hematocrit determinations 







Manual String Process 
Manual string method.  
For each bloodstain, the manual string method was utilized whereby each bloodstain was 
measured for length and width and the angle of impact was calculated using the equation arc sine 
= W/L. Once the angle of impact was calculated, a zero-edge protractor, in which the scale goes 
to the surface, is used in conjunction with a string to determine where the source of the blood 
was located at the time the blood spatter being analyzed was produced. First, the direction of the 







Figure 63. Directionality of blood spatter.(http://www.bloodspatter.com/bloodstain-tutorial-2) 
 
The protractor was placed at the point where the blood spatter impacted the surface 
(Figure 64). A string was secured to the surface by tape, pin, or adhesive clips (used in this 
study) (Figure 65). The string was then projected back in the same direction as the blood spatter 
would have originated and at the angle that the blood spatter impacted the surface. The string 
was pulled taut and secured on another wall or other object. The location of the blood spatter in 
the room was documented. For each blood spatter, the process was repeated – blood spatter 
width and length was measured, the angle of impact was calculated, directionality was 
determined, and the blood spatter was located in the room using a protractor and secured string. 
The site where the strings intersect is the area of origin of those blood spatters. The coordinates 
of the area of origin were documented and used as part of the crime scene reconstruction. This is 
one part of the reconstruction, and all of the evidence must be considered in order to reconstruct 






Figure 64. Zero edge protractor placement for string method. 
 
 
Figure 65. Strings used for manual string process. Note the use of different color strings. 
 
Computer Program and Digital Photographs 
In addition to the manual string approach to determine the area of origin, a computer 
program was utilized. The program was the HemoSpat® software, version 1.10, released 





and data entry of all of the coordinates for each bloodstain into the software. The digital 
photographs were obtained with a Canon SX420 IS digital camera (Canon U.S.A, Inc., 
Arlington, VA). The manual and computer-generated areas of origin were compared to the actual 
areas of origin for each blood density simulation. The steps to enter the digital photograph and 
associated location coordinates are given in Figure 65. 
 
HemoSpat® Bloodstain Pattern Analysis Software 
HemoSpat® Program Steps for collection of bloodstain data once digital 
photograph of bloodstain has been obtained 
Open program 
Click on “Create Project” 
Add values for walls, the front wall being the default wall the program measures the 
bloodstains. 
Open the document source of the bloodstain photos. 
INSERT IMAGES: Drag first bloodstain photo from their source and drag them into the 
green box stating “drop your stain images here.” Alternatively, the “File” button in the upper 
left-hand corner has an “import images” feature. Drag subsequent bloodstain photos onto the first 
bloodstain photo. 
Click on the bloodstain to be analyzed. Set the scaling to fit the screen as necessary. 
CROP: The program automatically sets the cursor to begin cropping. Click and hold to 






SELECT STAIN: Click the middle of the blood stain and the program measures the stain. 
If the outline of the computer’s recognition of the stain is incorrect press ESC, and click the 
middle of the stain again. When satisfied, press the lock button. 
SCALE: Drag and hold the mouse to draw a box around the metric side of the scale. 
When satisfied click the lock button. 
PLUM LINE: To orient the stain with regard to the plum line, click the middle of the 
picture and drag the digital plum line until it follows the plum line drawn on the scale. 
 
For each photo: 
Set the scale to 50 mm 
Record the Y and Z value in the program 
Orient the stain to the “front wall” using the drag-down drop box. 
Analysis: 
Click “View” in the upper left-hand corner. Click “2D VIEWS.” 
To export the analysis, click “File” in the upper left-hand corner. Click “export” and 
select the file type to be exported. “.txt” is the default analysis that opens in “Notepad,” and 
“Comma Separated” saves the data in Excel format.  
  
Figure 65. HemoSpat® program steps. 
 
Blood Spatter Simulations Process 
The first step was to create the blood spatter patterns that will be evaluated. 1 mL aliquot 
of the blood sample, maintained at 37 oC, was pipetted into the cut out in the ballistic gelatin 






Figure 66. Blood spatter device testing impact material. 
 
 
Figure 67 Blood spatter device testing.  
 
The bat was rotated until the springs are engaged and then released and allowed to strike 
the target producing blood spatter on the walls of the simulation room (Figure 68). Between each 





case it had moved from the previous simulation, and the x, y, and z measurements were 
documented (Figures 69-70). For each simulation, 10 bloodstains were identified and a 5 cm 
adhesive photographic scale was affixed next to each bloodstain and labeled with the bloodstain 
number. A plum line was dropped next to each bloodstain, and the line is traced on to the 
photographic scale associated with each bloodstain. The location of each bloodstain is 
documented by measuring the distance from the left wall (y), the distance from the floor (z), and 
the distance out from the front wall (x), if applicable. The measurements of each bloodstain were 
then determined; the width and the length were recorded. The next step was photographing each 
bloodstain with a digital camera. The pictures were downloaded into the HemoSpat software for 
the computer-generated analysis. Once the photography is completed, the task of completing the 
manual string analysis continued. From the width and length numbers, the arcsine was calculated 
and the angle of impact determined for each bloodstain. Using a zero edge protractor adjacent to 
the point where the bloodstain impacted the wall, a string was attached by means of an adhesive 
clip to the wall. The string was lined up with the appropriate angle of impact for the bloodstain 
from the protractor, and the string was extended back away from the stain until it was affixed to 
another wall or object. The string now approximated the path that this blood spatter followed 
from its origin until it impacted the wall. Different colored strings were used to help distinguish 
between bloodstains or simulations if the strings remained in place, creating a very complicated 
scenario. The strings for each simulation, after being documented, were removed before the next 
simulation took place. The process described above was repeated for each of the 10 bloodstains 
used in each simulation. The area(s) where the strings intersected (cross) represented the origin, 





bloodstains were produced on the walls of the room. Once the manual string process was 
completed, the computer-generated process was followed as outlined in Figure 50. 
 
Figure 68. Test of blood spatter device in simulation room. 
 
 







Figure 70. Room and spatter device set up for simulations. 
 
The entire process was repeated for each simulation utilizing the 5 different blood 
samples for a total of 25 simulations. Both the string method and the computer-generated method 
were very tedious and required a significant amount of diligence and expertise to be performed 
correctly and accurately. Each simulation took a minimum of 4 hours; therefore, the 25 
simulations required a minimum of 100 hours labor. 
Simulations Data Collection 
The tables that follow contain the data collected for each simulation (Tables 18-42). The 
figures (Figures 71, 74, 76-77, 80, 82-83, 85, 87, 89, 91, 93-94, 96, 98, 100, 102, 105-106, 108, 
111, 114, 116, 118-119, 121, 123, 125, 127, and 129) that follow are the computer generated 
simulations from the data in the tables and pictures (Figures 72-73, 75, 78-79, 81, 84, 86, 88, 90, 
92, 95, 97 ,99, 101, 103-104, 107, 109-110, 112-113, 115, 117, 120, 122, 124, 126, and 128) of 





simulations, as calculated by the manual string and software methods, are presented in Tables 
43-44.  
 
Table 18. Simulation 1.1 stain coordinate data 
 
In the above table under location, X is the distance out from the front wall, Y is the distance from 
the left wall and Z is the distance from the floor. For the known area of origin and the string 
method area of origin, X, Y, and Z were manually measured. For the HemoSpat® calculated area 
of origin, X, Y, and Z were computer generated. 
SIMULATION #1.1 - STAIN COORDINATE DATA
VERY LOW DENSITY BLOOD
LOCATION
BLOOD STAIN W L W/L ANGLE X Y Z
1 1.5 6 0.25 14.48 154 102
2 4 9 0.44 26.1 169 103
3 4 8 0.5 30 181 109
4 2.5 6 0.42 24.83 193 92
5 4 11 0.36 21.1 179 96
6 2.5 5 0.5 30 204 132
7 2 5 0.4 23.58 191 140
8 2.5 4 0.63 29.05 163 107
9 4 8 0.5 30 183 88
10 5 13 0.38 22.33 208 186
KNOWN AREA OF ORIGIN 31 119 45
STRING METHOD AREA OF ORIGIN 17 132 78
HEMOSPAT CALCULATED 28.9 123.1 91.6






Figure 71.  Simulation 1.1 computer-generated data. 
 
 


























Table 19. Simulation 1.2 stain coordinate data 
 
In the above table under location, X is the distance out from the front wall, Y is the distance from 
the left wall and Z is the distance from the floor. For the known area of origin and the string 
method area of origin, X, Y, and Z were manually measured. For the HemoSpat® calculated area 
of origin, X, Y, and Z were computer generated. 
 
SIMULATION 1.2 - STAIN COORDINATE DATA
VERY LOW DENSITY BLOOD
LOCATION
BLOOD STAIN W L W/L ANGLE X Y Z
1 1 4 0.25 14.5 51 60
2 1.5 4 0.38 22.3 46 65
3 1 3 0.33 19.3 28 70
4 2 6.5 0.31 18.1 49 69
5 3 5 0.6 36.9 115 121
6 4 9 0.44 26.1 122 120
7 4 9 0.44 26.1 124 125
8 4 10 0.4 23.6 125 143
9 2 4 0.5 30 137 135
10 3 8 0.38 22.3 128 152
KNOWN AREA OF ORIGIN 31 119 45
STRING METHOD AREA OF ORIGIN 16 128 76
HEMOSPAT CALCULATED 24.3 120 61.6






Figure 74. Simulation 1.2 computer-generated data. 
 
 






Table 20. Simulation 1.3 stain coordinate data 
 
In the above table under location, X is the distance out from the front wall, Y is the distance from 
the left wall and Z is the distance from the floor. For the known area of origin and the string 
method area of origin, X, Y, and Z were manually measured. For the HemoSpat® calculated area 
of origin, X, Y, and Z were computer generated. 
 
SIMULATION  #1.3 - STAIN COORDINATE DATA
VERY LOW DENSITY BLOOD
LOCATION
BLOOD STAIN W L W/L ANGLE X Y Z
1 3 7 0.43 25.5 201 181
2 3 9 0.33 19.3 185 152
3 3 9 0.33 19.3 182 147
4 2 5 0.4 23.6 180 124
5 4 8 0.5 30 207 169
6 2 5 0.46 23.6 156 150
7 1 4 0.25 14.5 162 162
8 2 4 0.5 30 157 137
9 1.5 4 0.38 22.3 169 165
10 5 12 0.42 24.8 191 148
KNOWN AREA OF ORIGIN 28 119 46
STRING METHOD AREA OF ORIGIN 18 129 87
HEMOSPAT CALCULATED 31.1 127.6 27.3






















Table 21. Simulation 1.4 stain coordinate data 
 
In the above table under location, X is the distance out from the front wall, Y is the distance from 
the left wall and Z is the distance from the floor. For the known area of origin and the string 
method area of origin, X, Y, and Z were manually measured. For the HemoSpat® calculated area 
of origin, X, Y, and Z were computer generated. 
 
SIMULATION #1.4 - STAIN COORDINATE DATA
VERY LOW DENSITY BLOOD
LOCATION
BLOOD STAIN W L W/L ANGLE X Y Z
1 3 10 0.3 17.5 125 138
2 1 5 0.2 11.5 134 151
3 2 10 0.2 11.5 120 152
4 4 13 0.31 18.1 110 167
5 1.5 4 0.38 22.3 130 102
6 1 5 0.2 11.5 30 71
7 2 4 0.5 30 65 64
8 2 10 0.2 11.5 185 147
9 3 5 0.6 36.9 69 66
10 1 4 0.25 14.5 113 120
KNOWN AREA OF ORIGIN 24 108 47
STRING METHOD AREA OF ORIGIN 15 117 72
HEMOSPAT CALCULATED 31.9 116.6 57.6






Figure 77. Simulation 1.4 computer-generated data. 
 
 

























Table 22. Simulation 1.5 stain coordinate data 
 
 
In the above table under location, X is the distance out from the front wall, Y is the distance from 
the left wall and Z is the distance from the floor. For the known area of origin and the string 
method area of origin, X, Y, and Z were manually measured. For the HemoSpat® calculated area 
of origin, X, Y, and Z were computer generated. 
 
SIMULATION #1.5 - STAIN COORDINATE DATA
VERY LOW DENSITY BLOOD
LOCATION
BLOOD STAIN W L W/L ANGLE X Y Z
1 4 15 0.27 15.7 114 136
2 2 7 0.29 16.9 112 135
3 3 5 0.6 36.9 133 100
4 3 5 0.6 36.9 138 117
5 1 4 0.25 14.5 168 164
6 1 5 0.2 11.5 203 153
7 1 4 0.25 14.5 119 128
8 1 5 0.2 11.5 137 180
9 1 5 0.2 11.5 130 173
10 1 4 0.25 14.5 28 77
KNOWN AREA OF ORIGIN 24 108 47
STRING METHOD AREA OF ORIGIN 20 111 69.5
HEMOSPAT CALCULATED 26.2 116.4 72.2






Figure 80. Simulation 1.5 computer-generated data. 
 
 






























Table 23. Simulation 2.1 stain coordinate data 
 
In the above table under location, X is the distance out from the front wall, Y is the distance from 
the left wall and Z is the distance from the floor. For the known area of origin and the string 
method area of origin, X, Y, and Z were manually measured. For the HemoSpat® calculated area 
of origin, X, Y, and Z were computer generated. 
 
SIMULATION #2.1 - STAIN COORDINATE DATA
LOW DENSITY BLOOD
LOCATION
BLOOD STAIN W L W/L ANGLE X Y Z
1 2 6 0.33 19.3 75 104
2 2 4 0.5 30 126 106
3 1 3 0.33 19.3 159 97
4 1 4 0.25 14.6 172 94
5 1.5 3 0.5 30 151 83
6 2 5 0.4 14.7 130 101
7 1 3 0.33 19.3 197 105
8 2 4 0.5 30 100 96
9 2 4 0.5 30 116 113
10 2 3 0.67 42.1 92 106
KNOWN AREA OF ORIGIN 25 107 44
STRING METHOD AREA OF ORIGIN 16 106 80
HEMOSPAT CALCULATED 34 108 53.4






Figure 83. Simulation 2.1 computer-generated data. 
 
 






Table 24. Simulation 2.2 stain coordinate data 
 
In the above table under location, X is the distance out from the front wall, Y is the distance from 
the left wall and Z is the distance from the floor. For the known area of origin and the string 
method area of origin, X, Y, and Z were manually measured. For the HemoSpat® calculated area 
of origin, X, Y, and Z were computer generated. 
 
SIMULATION #2.2 - STAIN COORDINATE DATA
LOW DENSITY BLOOD
LOCATION
BLOOD STAIN W L W/L ANGLE X Y Z
1 2 12 0.17 9.8 178 130
2 2 5 0.4 23.6 184 145
3 2 5 0.4 23.6 127 130
4 2 4 0.5 30 109 121
5 2 4 0.5 30 123 109
6 1 5 0.2 11.5 213 112
7 1 3 0.3 19.3 162 111
8 3 5 0.6 36.9 104 128
9 2 4 0.5 30 116 102
10 3 7 0.43 25.5 156 87
KNOWN AREA OF ORIGIN 25 107 44
STRING METHOD AREA OF ORIGIN 19 114 83
HEMOSPAT CALCULATED 31.5 111 71.8






Figure 85. Simulation 2.2 computer-generated data. 
 
 






Table 25. Simulation 2.3 stain coordinate data 
 
In the above table under location, X is the distance out from the front wall, Y is the distance from 
the left wall and Z is the distance from the floor. For the known area of origin and the string 
method area of origin, X, Y, and Z were manually measured. For the HemoSpat® calculated area 
of origin, X, Y, and Z were computer generated. 
 
SIMULATION #2.3 - STAIN COORDINATE DATA
LOW DENSITY BLOOD
LOCATION
BLOOD STAIN W L W/L ANGLE X Y Z
1 2 9 0.22 12.7 198 107
2 1 3 0.33 19.3 189 95
3 1 3 0.33 19.3 171 84
4 1 4 0.25 14.5 161 75
5 3 4 0.75 48.6 164 56
6 2 4 0.5 30 168 85
7 1 3 0.33 19.3 180 88
8 2 5 0.4 23.6 188 98
9 2 4 0.5 30 170 30
10 2 4 0.5 30 167 83
KNOWN AREA OF ORIGIN 29 117 47
STRING METHOD AREA OF ORIGIN 22 115 63
HEMOSPAT CALCULATED 20.2 137.6 65.3






Figure 87. Simulation 2.3 computer-generated data. 
 
 






Table 26. Simulation 2.4 stain coordinate data 
 
In the above table under location, X is the distance out from the front wall, Y is the distance from 
the left wall and Z is the distance from the floor. For the known area of origin and the string 
method area of origin, X, Y, and Z were manually measured. For the HemoSpat® calculated area 
of origin, X, Y, and Z were computer generated. 
 
SIMULATION #2.4 - STAIN COORDINATE DATA
LOW DENSITY BLOOD
LOCATION
BLOOD STAIN W L W/L ANGLE X Y Z
1 3 5 0.6 36.9 164 68
2 1 4 0.25 14.5 177 59
3 2 4 0.5 30 183 68
4 2 4 0.5 30 193 73
5 2.5 8 0.31 18.1 194 82
6 2 7 0.29 16.9 189 87
7 1 4 0.25 14.5 200 48
8 1 4 0.25 14.5 195 77
9 1 3 0.33 19.3 171 46
10 1 3 0.33 19.3 178 74
KNOWN AREA OF ORIGIN 26 117 45
STRING METHOD AREA OF ORIGIN 17 145 77
HEMOSPAT CALCULATED 7 175.5 66.5






Figure 89. Simulation 2.4 computer-generated data. 
 
 





Table 27. Simulation 2.5 stain coordinate data 
 
In the above table under location, X is the distance out from the front wall, Y is the distance from 
the left wall and Z is the distance from the floor. For the known area of origin and the string 
method area of origin, X, Y, and Z were manually measured. For the HemoSpat® calculated area 
of origin, X, Y, and Z were computer generated. 
 
SIMULATION #2.5 - STAIN COORDINATE DATA
LOW DENSITY BLOOD
LOCATION
BLOOD STAIN W L W/L ANGLE X Y Z
1 2 4 0.5 30 123 128
2 1 5 0.2 11.5 117 115
3 1.5 5 0.3 17.5 111 94
4 1 5 0.2 11.5 45 97
5 1 5 0.2 11.5 27 96
6 1.5 5 0.3 17.5 61 72
7 1 4 0.25 14.5 81 91
8 2 4 0.5 30 104 90
9 1.5 6 0.25 14.5 131 116
10 1.5 5 0.3 30 127 123
KNOWN AREA OF ORIGIN 23 117 45
STRING METHOD AREA OF ORIGIN 16 115 78
HEMOSPAT CALCULATED 24.5 122.1 57.7






Figure 91. Simulation 2.5 computer-generated data. 
 
 




























Table 28. Simulation 3.1 stain coordinate data 
 
In the above table under location, X is the distance out from the front wall, Y is the distance from 
the left wall and Z is the distance from the floor. For the known area of origin and the string 
method area of origin, X, Y, and Z were manually measured. For the HemoSpat® calculated area 
of origin, X, Y, and Z were computer generated. 
 
SIMULATION #3.1 - STAIN COORDINATE DATA
NORMAL DENSITY BLOOD
LOCATION
BLOOD STAIN W L W/L ANGLE X Y Z
1 1 10 0.1 5.7 45 100
2 1 4 0.25 14.5 40 69
3 1.5 5 0.3 17.5 39 97
4 1 4 0.25 14.5 29 101
5 1 3 0.33 19.3 136 139
6 1 4 0.25 14.5 139 133
7 1 4 0.25 14.5 172 161
8 2 5 0.4 23.6 152 162
9 1 7 0.14 8 179 196
10 1.5 4 0.38 22.3 59 89
KNOWN AREA OF ORIGIN 25 116 45
STRING METHOD AREA OF ORIGIN 20 117 80
HEMOSPAT CALCULATED 25.5 119 66.3






Figure 94. Simulation 3.1 computer-generated data. 
 
 






Table 29. Simulation 3.2 stain coordinate data 
 
In the above table under location, X is the distance out from the front wall, Y is the distance from 
the left wall and Z is the distance from the floor. For the known area of origin and the string 
method area of origin, X, Y, and Z were manually measured. For the HemoSpat® calculated area 
of origin, X, Y, and Z were computer generated. 
 
SIMULATION #3.2 - STAIN COORDINATE DATA
NORMAL DENSITY BLOOD
LOCATION
BLOOD STAIN W L W/L ANGLE X Y Z
1 1.5 5 0.3 17.5 147 116
2 2 4 0.5 30 141 98
3 2 4 0.5 30 139 119
4 1 4 0.25 14.5 132 107
5 2.5 4 0.63 39.1 72 64
6 3 7 0.43 25.1 71 69
7 1.5 4 0.38 22.3 58 85
8 2 4 0.5 30 49 99
9 2 4 0.5 30 76 81
10 1 3 0.33 19.3 150 123
KNOWN AREA OF ORIGIN 24 116 46
STRING METHOD AREA OF ORIGIN 16 124 80
HEMOSPAT CALCULATED 28.7 119.8 66.7






Figure 96. Simulation 3.2 computer-generated data. 
 
 





Table 30. Simulation 3.3 stain coordinate data 
 
In the above table under location, X is the distance out from the front wall, Y is the distance from 
the left wall and Z is the distance from the floor. For the known area of origin and the string 
method area of origin, X, Y, and Z were manually measured. For the HemoSpat® calculated area 
of origin, X, Y, and Z were computer generated. 
 
 
SIMULATION #3.3 - STAIN COORDINATE DATA
NORMAL DENSITY BLOOD
LOCATION
BLOOD STAIN W L W/L ANGLE X Y Z
1 1 6 0.17 9.8 44 92
2 1.5 6 0.25 14.5 48 96
3 1 4 0.25 14.5 22 79
4 1 3 0.33 19.3 34 109
5 1 3 0.33 19.3 43 86
6 1.5 4 0.38 22.3 142 114
7 1 4 0.25 14.5 40 91
8 1 3 0.33 19.3 51 82
9 1 3 0.33 19.3 66 82
10 1 3.5 0.29 16.9 45 54
KNOWN AREA OF ORIGIN 24 116 46
STRING METHOD AREA OF ORIGIN 13 87 68
HEMOSPAT CALCULATED 32.4 124.6 48.6






Figure 98. Simulation 3.3 computer-generated data. 
 
 





Table 31. Simulation 3.4 stain coordinate data 
 
In the above table under location, X is the distance out from the front wall, Y is the distance from 
the left wall and Z is the distance from the floor. For the known area of origin and the string 
method area of origin, X, Y, and Z were manually measured. For the HemoSpat® calculated area 




SIMULATION #3.4 - STAIN COORDINATE DATA
NORMAL DENSITY BLOOD
LOCATION
BLOOD STAIN W L W/L ANGLE X Y Z
1 2.5 6 0.42 24.8 133 130
2 3 11 0.27 15.7 108 152
3 1.5 6 0.25 14.5 130 117
4 2 5 0.4 23.6 129 97
5 2 5 0.4 23.6 181 85
6 1 3 0.33 19.3 192 95
7 2 3 0.67 42.1 125 90
8 1 3 0.33 19.3 128 89
9 2 3 0.67 42.1 122 124
10 2 5 0.4 23.6 128 122
KNOWN AREA OF ORIGIN 20 117 44
STRING METHOD AREA OF ORIGIN 20 115 75
HEMOSPAT CALCULATED 43.1 110.6 44.2






Figure 100. Simulation 3.4 computer-generated data. 
 
 






Table 32. Simulation 3.5 stain data coordinate 
 
In the above table under location, X is the distance out from the front wall, Y is the distance from 
the left wall and Z is the distance from the floor. For the known area of origin and the string 
method area of origin, X, Y, and Z were manually measured. For the HemoSpat® calculated area 
of origin, X, Y, and Z were computer generated. 
 
 
SIMULATION #3.5 - STAIN COORDINATE DATA
NORMAL DENSITY BLOOD
LOCATION
BLOOD STAIN W L W/L ANGLE X Y Z
1 1 9 0.11 6.3 191 126
2 1.5 6 0.25 14.5 187 148
3 1 7 0.14 8 161 121
4 1.5 5 0.3 17.5 136 135
5 2 9 0.22 12.7 127 150
6 1.5 6 0.25 14.5 116 125
7 2 5 0.4 23.6 135 100
8 1 3 0.33 19.3 74 94
9 1.5 3 0.5 30 76 84
10 1.5 4 0.38 22.3 163 91
KNOWN AREA OF ORIGIN 20 117 44
STRING METHOD AREA OF ORIGIN 17 113 77
HEMOSPAT CALCULATED 27.1 116.5 61.4






Figure 102. Simulation 3.5 computer-generated data. 
 
 






Figure 104. Simulation 3.5 string method construction. 
 
 





Table 33. Simulation 4.1 stain coordinate data 
 
In the above table under location, X is the distance out from the front wall, Y is the distance from 
the left wall and Z is the distance from the floor. For the known area of origin and the string 
method area of origin, X, Y, and Z were manually measured. For the HemoSpat® calculated area 




SIMULATION #4.1 - STAIN COORDINATE DATA
HIGH DENSITY BLOOD
LOCATION
BLOOD STAIN W L W/L ANGLE X Y Z
1 2 9 0.22 12.7 67 123
2 3 12 0.25 14.5 77 129
3 1 5 0.2 11.5 61 137
4 3 3 0.33 19.3 190 77
5 3 4 0.75 49 49 82
6 1 9 0.33 19.3 213 120
7 1 8 0.13 7.5 197 103
8 1 7 0.14 8 204 94
9 1 4 0.25 14.5 179 73
10 1 5 0.2 11.5 58 146
KNOWN AREA OF ORIGIN 25 101 44
STRING METHOD AREA OF ORIGIN 14.5 104 61
HEMOSPAT CALCULATED 24.5 104.6 52.4






Figure 106. Simulation 4.1 computer-generated data. 
 
 






Table 34. Simulation 4.2 stain coordinate data 
 
In the above table under location, X is the distance out from the front wall, Y is the distance from 
the left wall and Z is the distance from the floor. For the known area of origin and the string 
method area of origin, X, Y, and Z were manually measured. For the HemoSpat® calculated area 





SIMULATION #4.2 - STAIN COORDINATE DATA
HIGH DENSITY BLOOD
LOCATION
BLOOD STAIN W L W/L ANGLE X Y Z
1 1.5 5 0.3 17.5 162 135
2 1.5 5 0.3 17.5 154 130
3 1.5 5 0.3 17.5 144 134
4 2 4 0.5 30 142 143
5 2.5 5 0.5 30 129 109
6 1 4 0.25 14.5 109 79
7 1 4 0.25 14.5 30 54
8 1 3 0.33 19.3 29 57
9 2 4 0.5 30 126 126
10 1.5 3 0.5 30 173 132
KNOWN AREA OF ORIGIN 25 101 44
STRING METHOD AREA OF ORIGIN 20 102 60
HEMOSPAT CALCULATED 33.8 106 60.4






Figure 108. Simulation 4.2 computer-generated data. 
 
 




























Table 35. Simulation 4.3 stain coordinate data 
 
In the above table under location, X is the distance out from the front wall, Y is the distance from 
the left wall and Z is the distance from the floor. For the known area of origin and the string 
method area of origin, X, Y, and Z were manually measured. For the HemoSpat® calculated area 





SIMULATION #4.3 - STAIN COORDINATE DATA
HIGH DENSITY BLOOD
LOCATION
BLOOD STAIN W L W/L ANGLE X Y Z
1 3 12 0.25 14.5 209 88
2 1 5 0.2 11.5 187 85
3 2 8 0.25 14.5 198 82
4 1 4 0.25 14.5 178 58
5 1 4 0.25 14.5 174 79
6 1.5 4 0.38 22.3 163 57
7 4 10 0.4 23.6 158 60
8 1.5 6 0.25 14.5 186 51
9 1.5 4 0.38 22.3 141 29
10 1 4 0.25 14.5 161 41
KNOWN AREA OF ORIGIN 28 100 45
STRING METHOD AREA OF ORIGIN 15 121 70
HEMOSPAT CALCULATED 23.7 105.7 69.8






Figure 111. Simulation 4.3 computer-generated data. 
 
 






































Table 36. Simulation 4.4 stain coordinate data 
 
In the above table under location, X is the distance out from the front wall, Y is the distance from 
the left wall and Z is the distance from the floor. For the known area of origin and the string 
method area of origin, X, Y, and Z were manually measured. For the HemoSpat® calculated area 




SIMULATION #4.4 - STAIN COORDINATE DATA
HIGH DENSITY BLOOD
LOCATION
BLOOD STAIN W L W/L ANGLE X Y Z
1 1 4 0.25 14.5 105 110
2 3.5 7 0.5 23.6 103 99
3 3 8 0.38 22.3 110 100
4 1 3 0.33 19.3 188 121
5 1.5 4 0.38 22.3 100 93
6 1 6 0.17 9.8 170 117
7 2 8 0.25 14.5 204 135
8 2 10 0.2 11.5 209 143
9 1.5 5 0.3 17.5 160 92
10 1 4 0.25 14.5 178 91
KNOWN AREA OF ORIGIN 24 100 45
STRING METHOD AREA OF ORIGIN 20 102 77
HEMOSPAT CALCULATED 23.9 102.4 58.7






Figure 114. Simulation 4.4 computer-generated data. 
 
 





Table 37. Simulation 4.5 stain coordinate data 
 
In the above table under location, X is the distance out from the front wall, Y is the distance from 
the left wall and Z is the distance from the floor. For the known area of origin and the string 
method area of origin, X, Y, and Z were manually measured. For the HemoSpat® calculated area 




SIMULATION #4.5 - STAIN COORDINATE DATA
HIGH DENSITY BLOOD
LOCATION
BLOOD STAIN W L W/L ANGLE X Y Z
1 2 6 0.33 19.3 140 46
2 4 6 0.67 42.1 128 71
3 1.5 4 0.38 22.3 169 73
4 1 4 0.25 14.5 187 75
5 2 4 0.5 30 106 119
6 1 4 0.25 14.5 46 76
7 1 4 0.25 14.5 38 72
8 3 16 0.19 10.9 84 12
9 1.5 5 0.3 17.5 150 69
10 1.5 5 0.3 17.5 206 80
KNOWN AREA OF ORIGIN 24 100 45
STRING METHOD AREA OF ORIGIN 13 122 60
HEMOSPAT CALCULATED 24.1 100.8 54.5






Figure 116. Simulation 4.5 computer-generated data. 
 
 


































Table 38. Simulation 5.1 stain coordinate data 
 
In the above table under location, X is the distance out from the front wall, Y is the distance from 
the left wall and Z is the distance from the floor. For the known area of origin and the string 
method area of origin, X, Y, and Z were manually measured. For the HemoSpat® calculated area 








SIMULATION #5.1 - STAIN COORDINATE BLOOD
VERY HIGH DENSITY BLOOD
LOCATION
BLOOD STAIN W L W/L ANGLE X Y Z
1 1.5 5 0.3 17.5 39 86
2 1 3 0.33 19.3 33 78
3 1.5 4 0.38 22.3 43 81
4 1 3 0.33 19.3 50 74
5 2 3 0.67 42.1 61 75
6 1 3 0.33 19.3 68 65
7 2.5 3.5 0.71 45.2 107 71
8 2 2 1 90 114 65
9 1 3 0.33 19.3 39 56
10 1 3 0.33 19.3 56 68
KNOWN AREA OF ORIGIN 25 102 44
STRING METHOD AREA OF ORIGIN 17 105 56
HEMOSPAT CALCULATED 14.7 78.2 57.9















Figure 120. Simulation 5.1 string method construction. 
 
Table 39. Simulation 5.2 stain coordinate data 
 
SIMULATION #5.2 - STAIN COORDINATE DATA
VERY HIGH DENSITY BLOOD
LOCATION
BLOOD STAIN W L W/L ANGLE X Y Z
1 2 5 0.4 23.6 26 59
2 1.5 3.5 0.43 25.5 31 62
3 1.5 3.5 0.43 25.5 48 58
4 1.5 3 0.5 30 63 74
5 2 3.5 0.57 34.8 65 63
6 1.5 3 0.5 30 74 51
7 2.5 3 0.2 11.5 75 67
8 1.5 3 0.5 30 97 75
9 3 4.5 0.67 42.1 106 24
10 1 3 0.33 19.3 135 51
KNOWN AREA OF ORIGIN 25 102 44
STRING METHOD AREA OF ORIGIN 18 101 62
HEMOSPAT CALCULATED 23.1 102.1 46.2






In the above table under location, X is the distance out from the front wall, Y is the distance from 
the left wall and Z is the distance from the floor. For the known area of origin and the string 
method area of origin, X, Y, and Z were manually measured. For the HemoSpat® calculated area 











Figure 122. Simulation 5.2 string method construction. 
Table 40. Simulation 5.3 stain coordinate data 
 
SIMULATION #5.3 - STAIN COORDINATE DATA
VERY HIGH DENSITY BLOOD
LOCATION
BLOOD STAIN W L W/L ANGLE X Y Z
1 1 4 0.25 14.5 31 65
2 1.5 3 0.43 25.5 42 68
3 1 3 0.33 19.3 48 75
4 1 2.5 0.4 23.6 51 66
5 1.5 3 0.5 30 60 72
6 1 2.5 0.4 23.6 65 54
7 2 3.5 0.57 34.8 66 68
8 1.5 2.5 0.6 36.9 79 58
9 1 2 0.5 30 75 65
10 1 4.5 0.22 12.7 106 14
KNOWN AREA OF ORIGIN 25 102 44
STRING METHOD AREA OF ORIGIN 17 95 56
HEMOSPAT CALCULATED 21 100 53.3





In the above table under location, X is the distance out from the front wall, Y is the distance from 
the left wall and Z is the distance from the floor. For the known area of origin and the string 
method area of origin, X, Y, and Z were manually measured. For the HemoSpat® calculated area 












Figure 124. Simulation 5.3 string method construction. 
Table 41. Simulation 5.4 stain coordinate data 
 
SIMULATION #5.4 - STAIN COORDINATE DATA
VERY HIGH DENSITY BLOOD
LOCATION
BLOOD STAIN W L W/L ANGLE X Y Z
1 2 4 0.5 30 53 67
2 1 2.5 0.4 23.6 59 63
3 1 2.5 0.4 23.6 59 47
4 1.5 3 0.5 30 79 51
5 2.5 7.5 0.33 19.3 106 21
6 2 3 0.67 42.1 110 36
7 1 3 0.33 19.3 149 60
8 1 3 0.33 19.3 160 62
9 1 4 0.25 14.5 192 78
10 1 5.5 0.18 10.4 206 86
KNOWN AREA OF ORIGIN 23 104 45
STRING METHOD AREA OF ORIGIN 19 110 56
HEMOSPAT CALCULATED 20.5 100.6 48.6





In the above table under location, X is the distance out from the front wall, Y is the distance from 
the left wall and Z is the distance from the floor. For the known area of origin and the string 
method area of origin, X, Y, and Z were manually measured. For the HemoSpat® calculated area 













Figure 126. Simulation 5.4 string method construction. 
Table 42. Simulation 5.5 stain coordinate data 
 
SIMULATION #5.5 - STAIN COORDINATE DATA
VERY HIGH DENSITY BLOOD
LOCATION
BLOOD STAIN W L W/L ANGLE X Y Z
1 1 3 0.33 19.3 50 77
2 1 3 0.33 19.3 34 63
3 1 2.5 0.4 23.6 56 48
4 3 6 0.5 30 106 27
5 2 4 0.5 30 138 62
6 2.5 7 0.36 21.1 157 70
7 1 4 0.25 14.5 175 74
8 1.5 5 0.3 17.5 173 93
9 1 4 0.25 14.5 203 91
10 1 3.5 0.29 16.9 186 78
KNOWN AREA OF ORIGIN 23 104 45
STRING METHOD AREA OF ORIGIN 19 101 59
HEMOSPAT CALCULATED 24 107.3 52.8





In the above table under location, X is the distance out from the front wall, Y is the distance from 
the left wall and Z is the distance from the floor. For the known area of origin and the string 
method area of origin, X, Y, and Z were manually measured. For the HemoSpat® calculated area 












Figure 128. Simulation 5.5 string method construction. 
 






Table 43. Mean and SD of simulation sets for HemoSpat®  method  
HemoSpat
® 
mean mean mean SD SD SD 
simulation x y z x y z 
1.1-1.5 28.5 120.7 62.1 3.21 4.72 23.47 
2.1-2.5 23.2 130.6 62.6 10.61 27.3 7.56 
3.1-3.5 31.2 117.8 57.4 7.08 4.76 10.35 
4.1-4.5 26.0 103.8 59.0 4.47 2.28 7.0 






Table 44. Mean and SD of simulation sets for manual string method  
String mean mean mean SD SD SD 
simulation x y z x y z 
1.1-1.5 16.4 123.8 79.8 1.14 8.28 6.49 
2.1-2.5 18.0 119.6 76.2 2.54 14.41 7.72 
3.1-3.5 17.2 111.2 76.0 2.94 14.14 4.94 
4.1-4.5 16.4 112.2 65.6 3.36 13.46 7.63 
 17.8 101.8 57.8 0.83 5.35 2.68 
 
Research Questions and Research Hypotheses 





 RQ2a: To what extent are there differences between the known areas of origin of the 
bloodstains and the calculated areas of origin of the bloodstains obtained using the manual 
string approach at the five different blood densities? 
 RQ2b: To what extent are there differences between the known areas of origin of the 
bloodstains and the calculated areas of origin of the bloodstains obtained using the 
HemoSpat® program at the five different blood densities? 
 RQ2c: To what extent are there differences between the calculated areas of origin of the 
bloodstains obtained using the manual string approach and the HemoSpat® program at the 
five different blood densities? 
 RQ2d: To what extent are the differences between the known areas of origin of the 
bloodstains and the calculated areas of the bloodstains correlated with the angles of impact? 
The four associated research hypotheses are: 
 H2a: There are no differences between the known areas of origin of the bloodstains and the 
calculated areas of origin of the bloodstains obtained using the manual string approach at the 
five different blood densities. 
 H2b: There are no differences between the known areas of origin of the bloodstains and the 
calculated areas of origin of the bloodstains obtained using the HemoSpat® program at the 
five different blood densities. 
 H2c: There are no differences between areas of origin of the bloodstains calculated using the 
manual string approach and the HemoSpat® program. 
 H2d: The differences between the known areas of origin of the bloodstains and the calculated 








H2a, H2b, and H2c were tested by determining if the areas of origin of the bloodstains 
using one method were captured within the 95% CI of the calculated mean areas of origin of the 
bloodstains using another method. The two sets of 95% CI overlapped with each other, and the 
95% CI of the mean differences between the areas obtained with different methods captured 
zero. H2d was tested by drawing scatterplots to determine if the differences between the 
calculated areas of origin of the bloodstains minus the known areas of origin of the bloodstains 
were correlated with the angles of incidence at the five blood densities. Horizontal trend lines 
reflected no correlation. The effect sizes were indicated by R2 (i.e., the proportion of the variance 
in the differences explained by the angles of incidence. R2 < 0.04 reflected a negligible effect 
size) (Ferguson, 2009).  
Hypothesis H2a.  
Figure 130 is an error bar chart to determine the extent to which there are differences 
between the pre-defined known areas of origin of the bloodstains (K) and the calculated areas of 







Figure 130. Comparison of the known (K) and calculated areas of origin (M) obtained with the 
manual string method. Mean areas of origin are represented by circular symbols and the lower 
and upper bounds of the 95% CIs are represented by I symbols. 
 
The mean known areas of origin ranged from 57.1 at very high blood density to 62.7 at 
very low blood density. The mean calculated areas of origin ranged from 59.2 at very high blood 
density to 72.4 at very low blood density. No differences were indicated by the strong overlaps 
between the lower and upper boundaries of the 95% CI of the known and calculated mean areas 
of origin at each blood density. 
Figure 131 is an error bar chart to determine the extent to which zero was captured within 





areas of origin of the bloodstains obtained using the manual string method at the five blood 
densities. 
 
Figure 131. Comparison of mean differences between the known areas of origin minus the areas 
of origin obtained with the manual string method. Mean differences between areas of origin are 
represented by circular symbols and the lower and upper bounds of the 95% CIs are represented 
by I symbols. 
 
The mean differences ranged from -2.1 at very high blood density to -9.7 at very low 
blood density All of the 95% CI for the mean differences captured zero, implying that the mean 
differences were not significantly different from zero. Consequently, hypothesis H2a was 





calculated areas of origin of the bloodstains obtained using the manual string approach, at the 
five different blood densities. 
Hypothesis H2b.  
Figure 132 is an error bar chart to determine the extent to which there are differences 
between the pre-defined known areas of origin of the bloodstains (K) and the calculated areas of 
origin of the bloodstains obtained using the HemoSpat® program (H) at the five different blood 
densities. The mean known areas of origin ranged from 57.1 at very high blood density to 62.7 at 
very low blood density. The mean calculated areas of origin ranged from 56.9 at very high blood 
density to 70.4 at very low blood density. No differences were indicated by the strong overlaps 
between the lower and upper boundaries of the 95% CI of the known and calculated mean areas 






Figure 132. Comparison of the known (K) calculated areas of origin (H) obtained with the 
HemoSpat® program. Mean areas of origin are represented by circular symbols and the lower 
and upper bounds of the 95% CIs are represented by I symbols. 
 
Figure 133 is an error bar chart to determine the extent to which zero was captured within 
the 95% CI of the differences between the known areas of origin of the bloodstains (K) minus 
the areas of origin of the bloodstains obtained using the HemoSpat® program (H). 
 
Figure 133. Comparison of differences between the known areas of origin (K) minus the areas of 
origin obtained with the HemoSpat® program (H). Mean differences between areas of origin are 
represented by circular symbols and the lower and upper bounds of the 95% CIs are represented 






The mean differences (K-H) ranged from 0.4 at very high blood density to -10.5 at low 
blood density. All of the 95% CI for the mean differences captured zero, therefore the mean 
differences were not significantly different from zero. Consequently, hypothesis H2b was 
retained; there were no differences between the known areas of origin of the bloodstains and the 
calculated areas of origin of the bloodstains obtained using the HemoSpat® program, at the five 
different blood densities. 
Hypothesis H2c.   
Figure 134 is an error bar chart to determine the extent to which there are differences 
between the areas of origin of the bloodstains obtained with the manual string method (M) vs. 
the HemoSpat® program (H) at the five different blood densities. The mean areas of origin 
obtained with the manual string method ranged from 59.2 at very high blood density to 72.4 at 
very low blood density. The mean areas of origin obtained with the HemoSpat® program ranged 
from 56.7 at very high blood density to 70.4 at very low blood density. No differences were 
indicated by the strong overlaps between the lower and upper boundaries of the 95% CI of the 






Figure 134. Comparison of areas of origin obtained with the manual string method (M) and the 
HemoSpat® program (H). Mean areas of origin are represented by circular symbols and the 
lower and upper bounds of the 95% CIs are represented by I symbols. 
 
Figure 135 is an error bar chart to determine the extent to which zero was captured within 
the 95% CI of the differences between the areas of origin of the bloodstains obtained using the 
manual string method (M) minus the areas of origin of the bloodstains obtained using the 
HemoSpat program (H). The mean differences (M-H) ranged from 2.51 at very high blood 
density to -1.17 at low blood density. All of the 95% CI for the mean differences captured zero; 






Figure 135. Comparison of differences the areas of origin obtained with the manual string 
method (M) and the HemoSpat program (H). Mean difference between areas of origin are 
represented by circular symbols and the lower and upper bounds of the 95% CIs are represented 
by the I symbol. 
 
Therefore, hypothesis H2c was retained; there were no differences between areas of 
origin of the bloodstains calculated using the manual string approach and the HemoSpat® 
program. 
Hypothesis H2d.  
Figure 136 present scatterplots to determine if the differences between the calculated 
areas of origin of the bloodstains minus the known areas of origin of the bloodstains are 








Figure 136. Differences between known (K) and calculated areas of origin using manual string 
method (M) and HemoSpat® program (H) vs. angles of impact. 
 
The almost horizontal trend lines reflect little or no correlation. R2 = 0.0002 indicated that 
only 0.02% of the variance in the differences between the known areas and the areas calculated 





only 1.7% of the variance in the differences between the known areas and the areas calculated 
with Hemospat® was explained by the angle of impact.  
The effect sizes indicated by the very low values of R2 were negligible. Therefore, 
hypothesis H2d was retained; the differences between the known areas of origin of the 
bloodstains and the calculated areas of origin of the bloodstains were not correlated with the 
angles of impact. 
Conclusions 
There were no statistically significant differences between the known areas of origin of 
the bloodstains and the calculated areas of origin of the bloodstains obtained using the manual 
string approach for the five blood densities. There were no statistically significant differences 
between the known areas of origin of the bloodstains and the calculated areas of origin of the 
bloodstains obtained using the HemoSpat® program for the five blood densities. There were no 
statistically significant differences between areas of origin of the bloodstains calculated using the 
manual string approach and the HemoSpat® program. The differences between the known areas 
of origin of the bloodstains and the calculated areas of origin of the bloodstains were not 
correlated with the angles of impact. 
 
Chapter 4. Study 3:  Gunshot Blood Spatter 
Purpose and Plan 
The purpose of Study 3 was to examine the relationship between the blood density and 
the distance the blood travelled from the target. The blood densities were measured with the 
same scale used in Study 1 and Study 2 (1 = very low, 3 = low, 5 = normal, 6 = high, and 7 = 





target to simulate an exposed area of skin that has blood on its surface. The blood spatter was 
collected on poster board at five distances from the target (1, 2, 3, 4, and 5). The amount of blood 
spatter was measured in terms of the number of grids where the blood spatter was observed, at 
five distances from the target (Table 45). 
 
Table 45. Level designations of end of gun barrel to target 
Level Designation Distance from end of revolver barrel 
1 15 cm 
2 30 cm 
3 45 cm 
4 60 cm 
5 80 cm 
 
The firearm used was a 0.38 caliber Smith & Wesson Model 15 (Smith & Wesson, 
Springfield, MA) combat masterpiece 4 inch barrel revolver (Figure 137). The ammunition used 
was Fiocchi 0.38 special 130 grain, full metal jacket center fire cartridges (Giulio Fiocchi, Lecco, 
Italy)  (Figure 138). The ammunition head stamp was GFL (Giulio Fiocchi, Lecco, Italy) for the 
ammunition manufacturer. The ammunition manufacturer reported a muzzle velocity of 950 ft/s 






Figure 137. The 0.38 caliber Smith and Wesson revolver used in simulations. 
 
 










The site for Study 3 was the farm house that had been previously used for Study 2 testing. 
The house is set on over 100 acres, and the firing of a revolver did not cause concern to the 
neighbors. See Figure 65. 
Using Charlotte pipe 1 inch PVC piping a structure was built that would allow for 5 
levels (distances) of support for poster board measuring 72 cm x 56 cm. This structure had to 
allow for a bullet stop in its base and for the placement of ballistic gel blocks on top of the bullet 
stop. The bullet stop consisted of 50 lb bags of sand placed inside of a wooden box. On top of the 
box were placed 2 ballistic gel blocks, each measuring 10 cm x 22.5 cm x 10 cm, and on top of 
the 2 ballistic gel blocks was a third ballistic gel block. The third block served as the target. A 
section of the block measuring 2.0 cm x 2.5 cm x 0.2 cm was cut out of the block so that it would 
hold 1 mL of blood, essentially on top of the ballistic gel. This simulated uncovered (exposed) 
skin with blood on its surface. See Figures 139 through 144. 
The apparatus was tested to be certain that the sand was sufficient to trap the expended 
0.38 caliber projectile. It was found to be satisfactory, and additional sand bags were placed 
around the base in the event of a ricochet. Below the sand bags was a wooden floor. However, all 






Figure 139. Device to hold poster board sheets. 
 
 






Figure 141. Close up of the ballistic gel target. 
 
 
















For each simulation the following process was followed:  
 The poster board was identified with the blood density number, the position number, and test 
number. A hole measuring 2.5 cm x 2.5 cm was cut out from the center of the poster board to 
allow for the gun barrel to be placed through it.  
 The designated poster board was placed in the appropriate position on the device (based on 
the distance from the target).  
 The hole in the poster board was positioned over the target by use of a portable laser.  
 Once the poster board was set in its position, the blood appropriate sample was removed 
from the 37 oC water bath, and a Pasteur pipette was used to withdraw a blood sample 
aliquot. A 1 mL aliquot of the blood sample was then transferred to the target (the cut out 
area in the ballistic gel).  
 Next, the 0.38 caliber revolver was loaded with one 0.38 special cartridge, and the end of the 
revolver barrel was positioned inside of the hole in the poster board.  
 One shot, using single action to minimize movement of the revolver, was fired into the 
blood-covered target.  
 Once the projectile was fired, the poster board was removed from its designated position, and 
the blood spatter was allowed to dry.  
 Each poster board was photographed to document the blood spatter patterns for each 
simulation.  








Simulations Documentation and Data Collection 
The poster boards from the simulations had varying amounts of blood spatter on them, 
which could be described based on a visual observation (Figures 145 and 147). However, in 
order to quantitate the amount of blood spatter on each poster board, it was decided to use a grid 
system. A sheet of drafting paper measuring 79 cm x 60 cm was used, and a total of 154 equally 
sized grids, each measuring 5 cm x 5 cm, were drawn onto the tracing paper (Figure 148). The 
drafting paper was placed over each of the simulation poster boards, and the number of grids that 
contained any amount of blood spatter were counted (Figures 146 and 149). These data were 
used to evaluate the impact of the five blood densities on the distance the blood traveled from the 
target after being struck by a 0.38 caliber bullet, specifically, the distance the blood traveled from 
the target back towards the revolver (Tables 46-47 and Figure 150). 
 


















Figure 148. Grid used to count number of quadrants blood spatter was present. 
 
 








Table 46. Number of grids at each level by blood density 
Levels VLD LD ND HD VHD 
1 48 68 96 97 89 
2 57 82 46 70 66 
3 37 48 8 7 14 
4 21 5 4 8 23 
5 4 11 4 12 8 
 
Table 47. Number of grids by density at each level 
Density Level  1 Level 2 Level 3 Level 4 Level 5 
VLD 48 57 37 21 4 
LD 68 82 48 5 11 
ND 96 46 8 4 4 
HD 97 70 7 8 12 







Figure 150. Graph of number of grids with blood spatter to level by density. 
 
Study 3 Research Questions and Hypotheses 
RQ3: To what extent is the distance that the blood travels from the target correlated with 
the blood density? 
H3: The distance that the blood travels from the target is correlated with the blood 
density. 
H3 was tested visually by plotting the variations in the amount of blood spatter (number 
of grids) vs. the blood density, and the distance from the target, and statistically by conducting 






























dependent variable are equal across all levels of an independent variable, while statistically 
controlling for the effects of covariates, confounding, or nuisance variables (Belin & Norman, 
2009; Rutherford, 2001). ANCOVA was conducted to exclude the effects of the highly variable 
amount of blood spatter from the relationship between the distance the blood travelled from the 
target and the blood density. The distance from the target was the dependent variable. The blood 
density was the independent variable. The amount of blood spatter was the covariate because it 
confounded the relationship between the distance travelled and the blood density. The effect size 
was indicated by η2; assuming η2 < 0.04 was a negligible effect size (Ferguson, 2009). 
Data Analysis 
This section provides the results of the analysis to address the questions RQ3 and the 
associated hypotheses H3. Figure 151 plots the variations in the amount of blood spatter (number 
of grids) vs. the blood density (1 = very low, 3 = low, 5 = normal, 6 = high, and 7 = very high) 
and the distance from the target (1, 2, 3, 4, and 5). The amount the blood spatter at each of the 
five blood densities was correlated with the distance from the target. When the distance from the 
target = 1, the number of grids where blood was observed across the five blood densities was the 
highest, ranging from 48 to 96. When the distance from the target = 2, the number of grids where 
blood was observed across the five blood densities was lower, ranging from 57 to 82. When the 
distance from the target = 3 the number of grids where blood was observed across the five blood 
densities, was lower, ranging from 7 to 48. When the distance from the target = 4 the number of 
grids where blood was observed across the five blood densities was lower, ranging from 4 to 23. 
When the distance from the target = 5, the number of grids where blood was observed across the 






Figure 151. Blood spatter (number of grids) vs. blood density and distance from the target.  
 
Figure 152 is an error bar chart to illustrate the mean amount of blood spatter (number of 
grids) ± 95% CI at the five distances from the target across the five blood densities. The mean 
amount of blood spatter declined systematically with respect to the distance from the target. The 
mean number of grids where blood was observed ranged from a maximum of 79.6 when the 
distance from the target = 1 to a minimum of 7.8 grids when the distance from the target = 5. The 
effect size was R2 = 0.753, implying that 75.3% of the variance in the amount of blood spatter 































































Figure 152. Comparison of the amount of blood spatter vs. distance from target. Mean amount of 
blood spatter represented by circular symbols and the lower and upper bounds of the 95% CIs 
are represented by I symbols. 
 
The data presented in Figures 151-152 emphasized that the highly variable amount of 
blood spatter at each distance from the target confounded the relationship between the distance 
the blood travelled from the target and the blood density. 
Analysis of covariance (ANCOVA) was conducted to exclude the effects of the highly 
variable amount of blood spatter from the relationship between the distance the blood travelled 
from the target and the blood density. The distance from the target was the dependent variable. 
The blood density was the independent variable. The amount of blood spatter was the covariate 
(i.e., a variable that confounds the relationship between an independent and a dependent 
variable). ANCOVA was used to control the value of the covariate. Specifically, the amount of 










































adjusted mean values ± 95% CI of the distances of the blood spatter travelled from the target, 
after controlling for the amount of blood spatter, at each of the five blood densities.  
 
Figure 153. Comparison of adjusted distance blood travelled from target vs. blood density. 
Adjusted mean values of distance blood traveled to the target represented by circular symbols 
and the lower and upper bounds of the 95% CI are represented by I symbols.  
 
The mean adjusted distances that the blood travelled from the target, after controlling for 
the amount of blood scatter, ranged from 2.78 to 3.10. The strongly overlapping 95% CI 
reflected little difference between the mean differences distances. The effect size (η2 = 0.053) 
was very small (i.e., only 5.3% of the variance was explained). However, this effect size was just 
above criterion of Ferguson (2009) that the absolute minimum effect size to indicate a practically 





Because the effect size (indicated by the low value of η2) was very small, and the 
confounding effects of the highly variable amounts of blood spatter were high, the correlation 
between the distance that the blood travelled from the target and the blood density was difficult 
to evaluate. The results indicated that there was little evidence to support H3: The distance that 
the blood travels from the target is correlated with the blood density (Fisher R., personal 
communication 5/13/18). 
Conclusions 
Is the distance that the blood travels from the target correlated with the blood density? 
The data indicated that there is no correlation between the blood density and the distance the 
blood travels from the target after it is impacted with a 0.38 caliber projectile. 
 
Chapter 5. Quality Assurance at the Crime Scene and the Crime Lab 
Crime Scene Investigation 
Blood pattern analysis is a component of crime scene reconstruction. The manner in 
which blood was deposited at a crime scene can be a critical part of the overall reconstruction of 
the sequence of events that occurred before, during, and following the incident being 
investigated. “Blood pattern analysis is an activity that is subsumed under scientific crime scene 
investigation and reconstruction.” ( DeForest, 2018). Blood pattern analysis may be able to 
provide investigative information which could be helpful to those charged with investigating the 
incident. Blood pattern evaluation in some cases might have more value than DNA evidence, 
particularly if there is no issue about the origin of the blood stains. 
Unfortunately, very often blood pattern evidence is either overlooked or misinterpreted. 





The investigation of a crime scene, making decisions about which items constitute 
evidence that should be collected for further crime lab evaluation and which items need to be 
documented, is a very complex process. “Interpreting the physical traces at a potential crime 
scene is a scientific problem - a very demanding scientific problem! Knowledge of natural 
phenomena, extensive experience and a high level of proficiency with hypothesis development, 
hypothesis testing and scientific reasoning are all necessary.” (DeForest 2018). In many cases, 
these decisions are made by individuals who are not trained in criminalistics, but are usually 
crime scene technicians. These technicians typically receive their direction, i.e., what is evidence 
and what should be collected, from the investigating officer.  
It is imperative that a crime scene investigator evaluate all of the relevant evidence before 
coming up with a crime scene reconstruction scenario. The investigator must not introduce any 
potential bias as to what they think occurred and only look for evidence which supports their 
theory. The crime scene investigator has the task of evaluating which items require further 
analysis, what needs to be documented, and whether there is a single crime scene or multiple 
crimes scenes; all of this in a process which provides impartial conclusions, which may be 
contrary to the direction in which the investigating police agency is pursuing. “The approach to 
the recognition of relevant physical traces cannot be formulaic. It must be continually developed 
and refined de novo using the scientific method. In addition to the fundamental science 
education, the scientific investigator must also have both detailed training and extensive 
experience with crime scenes.” (DeForest, 2018). If the incident is a homicide, then the body of 
the deceased is evidence, including their clothing and material which may be on the clothing, 





Crime scene investigations cannot be rushed, as they require a very detailed and 
meticulous evaluation of the evidence or potential evidence and its juxtaposition to other items at 
the scene.  
The individual, evaluating the scene, making the decisions about evidence, documenting, 
and evaluating all the other myriad of items that require consideration in this very complex 
exercise of scene reconstruction, should be a highly trained scientist, or more specifically, a 
criminalist. A criminalist is a generalist who may have additional expertise in a forensic 
specialty. As a generalist, the criminalist has training and experience in evaluating all of the 
different types of evidence that may be encountered at a crime scene. He/she formulates 
decisions on which items should be collected for further testing as well as items needing 
evaluation at the scene.  
Blood pattern analysis requires evaluation at the scene before items are moved and spatial 
relationships change. A crime scene is a very fragile place, many things can impact how the 
evidence may be perceived. What has changed since the event took place? Did first responders 
move certain items and were additional blood patterns created which had nothing to do with the 
initial scene? There are a variety of ways in which a crime scene can be contaminated or altered. 
Again, this is a complicated process and must be handled by an appropriate expert, the 
criminalist. 
A Texas homicide case, in which an individual, Joe Bryan, who was convicted of the 
murder of his wife largely based on blood spatter testimony, is one example of the way in which 
bloodstain pattern analysis can be misinterpreted by those not appropriately trained. “Through 
the 1960’s, analyzing bloodstain patterns was the province of forensic scientists with years of 





pattern analysis became more popular, individuals with little scientific training who have taken a 
weeklong course became bloodstain pattern analysts, and these “experts” were accepted in many 
cases by the courts. “An influential state commission said the blood spatter analysis used to 
convict a former Texas high school principal of murdering his wife in 1985 was “not accurate or 
scientifically supported” and the expert who testified was entirely wrong. The findings of the 
Texas Forensic Science Commission, a national leader in forensic science reform, called into 
question the conviction of Joe Bryan, who has now spent more than 30 years in prison.” (Colloff, 
P., 2018). There is now a Texas statute requiring “that bloodstain pattern analysis be performed 
by an accredited organization, which should make it harder for prosecutors to introduce 
testimony by analysts with minimal training and qualifications.” (NY Times, 5/31/18). 
 
Crime Scene and Crime Lab Management: The Role of the Criminalist. Who is in Charge? 
The concept of crime scene management is an important matter. It means someone has 
responsibility for the overall crime scene and is making the important decisions about 
documentation recovery, resources required, how long to maintain the scene, etc. This should be 
the criminalist (generalist), as this individual is best equipped to make the vital decisions 
necessary so that a valid crime scene reconstruction is performed. “Scientists with experience at 
scenes need to have authority over all physical evidence, including the victim’s body, if one is 
present, up until the time it is delivered to the forensic pathologists for autopsy.” (DeForest, 
2018). This concept runs contrary to most jurisdictions, where the police investigator is in charge 
of the scene and most likely reluctant to give up this control.  
The crime scene - crime lab interaction is the concept of crime scene management should 





are linked in some manner. For example, a homicide takes place in a house, the body is 
transported in a vehicle to a remote area, and the body set on fire. There are at least four 
connected crime scenes: the house, the vehicle, the site where the body was burned, and of 
course, the body itself.  
The criminalist will interact with the forensic specialists in the crime lab so they both 
have an understanding of which evidentiary items are important and why. “Think of 
criminalistics as an orchestra. Each of the specialization areas is required to play a symphony. 
But a conductor keeps them all together, playing the same orchestral piece, in the same time, and 
lets each section know when their part is required, when solos begin, when they end. And think 
of the tools that we acquire, no matter how sophisticated, as a musical instrument.” (Hunter, 
2000). A review of the scene and how the evidence may help in the scene reconstruction, which 
is very valuable as compared to just receiving a bag of clothes and performing “standard” testing.  
The concept that crime scene management continues with management of the evidentiary 
analysis at the crime lab would, in my opinion, make the analysis process more efficient and 
valuable to the criminal justice system.  
Very often crime scene technicians, at the request of the investigating officer, will collect 
a large amount of “evidence” items for fear they might miss something. I call this “evidence 
pollution.” This mass of items is submitted to the crime lab in the typical way and with little to 
no guidance as to what may be of value forensically. The crime lab scientist will perform their 
usual testing and write the standard report and will have no idea as to whether their testing was 
relevant or even evaluated in the full context of a crime scene reconstruction.  
The Texas Legislature passed SB-1287, which requires all forensic analysts to be 





laboratory accredited by the State, reviews, performs, draws conclusions from, or interprets a 
forensic analysis for a court or crime laboratory (Tex S.B. 1287). The following forensic 
disciplines require accreditation: seized drugs testing, toxicology testing, forensic biology, 
firearms/toolmarks, document examination, materials (trace) analysis, and other disciplines if 
accredited by a recognized accrediting body and approved by the commission (Adm Code, 
651.5). No crime laboratory accreditation is required for the following disciplines: latent print 
examination, breath specimen testing, and digital evidence testing (Adm Code, 651.6). The 
Texas statute is generally a step in the right direction. However, if there is no accreditation for a 
specific analysis, these tests would not be admissible and could lead to an injustice. A novel 
approach that may exonerate an individual would not be allowed in court. 
 
Outsourcing Forensic Testing 
A common situation in the pharmaceutical industry is the outsourcing of bioanalytical 
testing to a contract research organization (CRO). The primary reason for outsourcing is 
timelines, the requirement to provide bioanalytical data to regulating agencies, primarily the U.S. 
FDA, so that companies can submit their applications for new biologic or chemical entities in a 
timely manner. The lab must meet criteria under the U.S. FDA Good Laboratory Practice (GLP) 
and Good Clinical Practice (GCP) to perform preclinical and clinical testing. There is a very 
comprehensive quality process, which is an integral part of the laboratory testing (Organization 
for Economic Co-operation and Development (OECD) principles of GLP). QA encompasses 
“those laboratory operations that ensure that quality control procedures are properly 
implemented; that the accountability of data is maintained; and that every reported result is 





the instrument used). The components of a QA program include the use of proper quality control 
(QC) samples, the use of validated testing procedures, timely evaluation of QC sample results 
using appropriate statistical processes to detect problems both in individual batches and on an 
on-going basis, and implementation of necessary corrective actions to eliminate problems.” 
(National Laboratory Certification  Program (NLCP), 2000). The quality process includes the 
following elements: 
 Standard operating procedures (SOP) 
 Validation protocols 
 Sample analysis protocols 
 Qualification (validation) of all instruments 
 Traceable standards and references 
 Each analytical run is independent with separate QC samples, standards, and controls 
 Strict criteria for accepting an analytical run 
 100% QC of all data 
 All testing is overseen by a project manager, who is a senior scientist and is responsible for 
approving the analytical runs and data 
 Independent QA Group – audit 100% of validation data and at least 10% of all analytical data  
Comparison of the various laboratory types is presented in Table 48. Table 49 compares 









Table 48. Laboratory testing comparison: clinical, GLP, GCP, and forensic 
Lab Type Purpose of Testing Results Interpreted 
by 
End User of Data 
Clinical Diagnosis Physician Physician 
























Table 49. Laboratory comparison bioanalytical CRO to forensic lab 
Requirements CRO Bioanalytical Forensic Lab 
Lab accreditation Yes, CLIA, GLP, GCP Yes 
Scientist certification Yes, CLIA Available 
Guidance documents Yes Yes 
Regulatory inspections Yes, unannounced Yes, announced 
Client audits Yes, annually No 
SOPs and procedures Yes Yes 
QC process Yes, 100% Yes 







Yes, including reanalysis Varies 
Scientist proficiency Yes, semi-annual Varies, accreditation require proficiency 
External proficiency Yes Varies, accreditation requires 
proficiency 
Blind reanalysis Yes No 
Double blind reanalysis Yes No, difficult to manage 
Responsible for oversite Project Manager Lab Manager or Criminalist 
 
The QA Department checks for compliance with SOPs and procedures; if there is non-
compliance, a deviation report is written. This must be addressed by the lab scientist and project 
manager and signed by the lab senior management and QA director. All deviations are tracked.  
In addition to all of the safeguards built into the testing process, the CRO lab is subject to 
unannounced inspections by the FDA. A typical FDA audit involves 4-6 auditors and can last 
several weeks. Besides the audits mandated by regulatory agencies, the lab is also audited by 
client QA teams at least annually for each client.  
The quality system in a U.S. Department of Health and Human (HHS) Services 
Substance Abuse and Mental Health Services Administration (SAMHSA) approved laboratory 
performing workplace drug testing is another model of a QA process designed to provide 
safeguards against inaccurate results. There exists a system of proficiency testing (PT) and QC 
built into the processes of the SAMHSA-approved lab. Blind testing PT samples submitted 
quarterly to the lab by HHS are analyzed by the lab following its “normal” testing protocol with 
results reported back to HHS (Mandatory Guidelines for Federal Workplace Drug Testing 





runs. Also, double blind samples are prepared, pre-analyzed, and submitted as routine specimens 
by the client.  
In addition to the above QA testing, there is a scheduled audit every six months by 
auditors who are a combination of contract auditors and HHS staff members.  
What Should Be the Model for Forensic Services? 
I would propose taking relevant portions from each of the above models to create a 
comprehensive quality program for forensic labs, which would include the following elements: 
1. Crime scene investigation under the control of the criminalist /generalist. 
2. Lab testing performed and results reviewed under the direction of criminal/generalist. 
3. SOPs providing general guidance, allowing for “non-standard” evidence. 
4. 100% QC of all data by a 2nd party. 
5. A separate and independent QA Department to oversee all aspects of quality, including 
conducting QA audits of all reports and all lab operations.  
6. Incorporation of blind QC samples into all runs. 
7. Double blind submissions, similar to blind proficiency samples that are received from a 3rd 
party. Though this would be difficult to manage, in the case of CDS (controlled dangerous 
substances) it is doable using pretested samples that are scheduled for destruction. For other 
testing a contractor would need to simulate a case and associated evidence and submit as 
routine evidence.  
8. Inspections by regulatory agencies resulting with real ramifications if problems are found. 
These inspections would include unannounced site visits performed by professionals that are 





9. Auditing of court testimony by lab management or the criminalist/generalist to ensure the 
testimony is consistent with the results. This is best accomplished by reviewing testimony 
transcripts. 
10. The forensic labs should be independent and separate from the police department and/or 
prosecutor’s office. It should include equal fee-based access to its testing services by both the 
prosecution and defense. The question of payment for an indigent defendant is a significant 
issue. “A strong recommendation of the NAS (National Academy of Science) report, 
published in 2009, was that forensic labs establish independence from law enforcement.” 
(Rudin & Inman, 2015). “The scientific analysis of forensic evidence can be essential to 
solving crimes, but as long as the process is controlled by the police and prosecutors, and not 
scientists, there will never be adequate oversight” (NY Times, 2018). 
11.  Outsourcing the appropriate routine testing to a CRO to ensure timely reporting and to ease 
the testing burden on the forensic lab. The outsourced forensic labs should have all of the 
quality procedures proposed above.  
There are many similarities between a regulated bioanalytical lab and a forensic lab. Both 
work with non-standard material, such as a new biological or chemical entity in the case of a 
bioanalytical laboratory and evidentiary items (there is no standard evidence) for the forensic lab. 
Both are intellectual endeavors requiring a creative, scientific thought processes within a 
regulatory or legal framework. Each involves scientific problem-solving which drives the 








Chapter 6. Research Conclusions 
The goal of this research was to determine if change in the physical property of blood had 
an impact on blood stain patterns in forensic investigations. 
Study 1 was designed to determine if a change in the physical property of human blood 
would impact the geometry of resultant blood stains when blood, dropping only under the 
influence of gravity, impacts a surface at various angles. 
The conclusions from Study 1 were that there is an impact on blood stain geometry and 
other aspects of the blood stains, including color and presence of tails. However, there is no 
effect on the calculated angles of impact. The comparison of normal human blood to very high 
density and very low density samples did not show a statistically significant difference on the 
calculated angle of impact.  
The purpose of Study 2 was to determine if changes in the physical properties of human 
blood had an impact on the determination of area of origin from blood spatter that was produced 
by striking a blood-covered target with a baseball bat. A comparison was made between the 
determination of the area of origin using a manual string method and using a commercially 
available software program, HemoSpat®.  
The conclusions reached from Study 2 were that there is no difference between the blood 
densities in determining the area of origin. Additionally, both the manual method and the 
computer program method were equivalent. The area of origin terminology was used in this 
dissertation to describe the location of the blood source at the time the blood spatter was 
produced. The volume of origin terminology better describes the physical situation as the origin 





The purpose of Study 3 was to determine if blood of different densities traveled further 
when a target with blood on its surface was struck by a 0.38 caliber projectile.  
The Study 3 conclusion was there is no statistical difference in the distance the blood 
traveled. 
 
Chapter 7. Contribution to the Field of Forensic Science and Criminal Justice 
This research intended to answer or clarify a number of questions related to bloodstain        
pattern analysis (BPA). These questions include: 
 When the physical characteristics of an individual’s blood are outside of the normal range, as 
in some blood disorders and other disease conditions, how does this impact bloodstain 
patterns from that individual’s blood? Is there the potential to misinterpret the bloodstain 
patterns and could this result in crime scene reconstruction errors? 
 Are the differences from normal blood statistically significant given the errors in manual 
measurements as well as in bloodstain selection? 
 This research included recommendations for a quality assurance process at crime scenes with 
a focus on BPA. The key elements of a QA program were discussed. A critical component in 
the process is the role of a criminalist/generalist, who has the ability to review the evidence 
and reach an independent conclusion regarding the BPA. This quality process extends to the 
nature and extent of documentation and preservation that is reasonable and expected. The 
need for a criminalist’s review is to answer the question has all the evidence been 
recognized? Additionally, the criminalist is part of the decision making process as to what is 
relevant and should be further evaluated. Crime scene reconstruction must consider all of the 





hypothesis will be tested against the observations (evidence) and modified if the data do not 
fit. Of course, this assumes that all of the “relevant” evidence has been identified, 
documented, and collected where possible. 
 This research utilized digital measuring and computer assisted data analysis in the bloodstain 
pattern examinations. This research provided a better understanding of the value of this 
technology and suggested enhancements that could provide more complete analysis, 
especially of physical parameters that are assumed to be relatively constant in a narrow 
window of inter-personal variation. 
 This research has shown that there is not material or statistically significant impact on BPA 
on bloodstain patterns when the physical properties of the blood are outside of the normal 
range. That finding is still an important contribution to the field and adds to the scientific 
validity of bloodstain pattern analysis. 
 In Daubert vs. Merrell Dow Pharmaceuticals (Daubert), The United States Supreme Court 
considered the question of the admissibility of novel scientific evidence. The Supreme Court 
suggested factors that should be used to determine the reliability of a scientific theory or 
technique. These are known as the Daubert Factors, and they are the following. 
o Has the scientific theory or technique been tested and are the methods based on a testable 
hypothesis? 
o Has the scientific theory or technique been subjected to peer review and publication? 
o What are the known or potential error rates of the theory or technique when applied? 





o Has the theory or technique been generally accepted in the relevant scientific 
community? (Foster & Huber, 1999; James & Nordby, 2003; Saferstein, 2005; Willis et 
al., 2001; FBI Lab, 2008; and Daubert vs. Merrell, 1993). 
The research in this thesis has added to the scientific knowledge regarding BPA. An 
evaluation of error rates is also a component of this research. The quality assurance 
recommendations in the thesis should serve to complement the standard and control requirements 
within the Daubert Factors. In summary, this research should provide additional data to 
complement the scientific validity of conclusions reached based on bloodstain pattern analysis.  
 
Chapter 8. Future Work and Additional Areas for Research 
There are many areas of additional research and study needed when it comes to scientific 
scene reconstruction and blood pattern analysis. The first is a better understanding of the training 
and educational requirements to prepare individuals for this complex task. This could be at a 
minimum university-based master’s level formal educational program. The second is technology 
that will assist in evaluating items that may provide additional information about the incident, 
such as the color and geometry of bloodstains. More efficient software for scene documentation, 
including individual stain coordinates, would be valuable. A new device that may assist in crime 
scene documentation is the Leica ScanStation (Leica Geosystems AG, Hexagon, Stockholm, 
Sweden). The ScanStation measures everything within its line of sight instead of only what an 
investigator thinks is important at the time. At a later date, investigators can view the scene to 
examine any geospatial relationships that become relevant (Leica Geosystems, 2018). 
Research in the development of techniques to analyze bloodstains for therapeutic agents 





useful in cases where a body has been removed from the scene of a homicide. From this analysis, 
one may be able to discern medical conditions that the individual may have, which could be of 
value as investigative aids. More research into the role of a criminalist/generalist in crime scene 
management and in overall case management is needed to maximize the potential evidence 
available and to put it in the appropriate perspective without preconceived theories of the crime. 
All of the above would help in demonstrating that bloodstain pattern analysis is a “legal” science 
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Certificates of Analysis 
 
 
PRODUCT: HUMAN SERUM 
CATALOG # HMSRM 
ANTICOAGULANT: 
NONE LOT#: BRH1399238 
STORAGE TEMPERATURE: -20 0 C OR COLDER 










PRESENTATION: 1 LOT OF 100 ML (1 X 100 ML) OF 





BIOHAZARD INFO: THIS MATERIAL SHOULD BE HANDLED AS IF CAPABLE 
OF TRANSMITTING INFECTIOUS AGENTS. PLEASE USE UNIVERSAL PRECAUTIONS. 
NO TEST METHOD CAN PROVIDE 
TOTAL ASSURANCE THAT HEPATITIS B VIRUS, HEPATITIS C VIRUS, HUMAN 
IMMUNODEFICIENCY VIRUS, OR OTHER INFECI'IOUS AGENTS ARE ABSENT. THUS, 
ALL BIOLOGICAL PRODUCI'S THAT WE 
PROVIDE SHOULD BE HANDLED AT THE BIO-SAFETY LEVEL 2 AS 





AND BIOMEDICAL LABORATORIES, FROM POTENTIALLY INFECTIOUS HUMAN 
SERUM OR BLOOD SPECIMENS" 
THE MATERIAL LISTED ON THIS CERTIFICATE OF ANALYSIS HAS BEEN 
TESTED IN ACCORDANCE WITH FDA REGULATIONS AND FOUND TO BE 
NEGATIVE FOR HIV 1/2 AB AND HCV AB AND NON-REACTIVE FOR HBSAG, HIV-I 
RNA, HCV RNA, HBV DNA AND STS. 
THIS PRODUCT IS BEING SOLD FOR RESEARCH AND OR MANUFACTURING 
PURPOSES ONLY. IT IS NOT TO 
BE USED IN HUMANS OR ANIMALS AND FURTHER MANUFACTURING THA T 
WILL RESULT IN A FINISHED PRODUCT THAT CONTAINS VIABLE LEUKOCYTES IS' 
PROHIBITED. FOR IN VITRO USE ONLY. THE USER 
ASSUMES ALL RESPONSIBILITY FOR ITS USAGE AND DISPOSAL. IN 
ACCORDANCE WITH ALL REGULA TIONS. 
 
PRODUCT: HUMAN RED BLOOD CELLS CATALOG # HMRBCNAHP 
ANTICOAGULANT: SODIUM HEPARIN 
LOT#: BRH1399239 
STORAGE TEMPERATURE: 40 C 
COA DATE: 190CT2017 
PURCHASE ORDER: VISA 
PROJECT NUMBER: 1268023 
VOLUME SHIPPED: 75 ML 
PRESENTATION: 1 LOT OF 75 ML (1 X 75 ML) OF 
HUMAN 
RED BLOOD CELLS 
EXPIRATION: 19NOV2017 
BIOHAZARD INFO: THIS MATERIAL SHOULD BE HANDLED AS IF CAPABLE 
OF TRANSMITTING INFECTIOUS AGENTS. PLEASE USE UNIVERSAL PRECAUTIONS. 





TOTAL ASSURANCE THAT HEPATITIS B VIRUS, HEPATITIS C VIRUS, HUMAN 
IMMUNODEFICIENCY VIRUS, OR OTHER INFECTIOUS AGENTS ARE ABSENT. 
THUS, ALL BIOLOGICAL PRODUCTS THAT WE 
PROVIDE SHOULD BE HANDLED AT THE BIO-SAFETY LEVEL 2 AS 
RECOMMENDED BY THE CDC/NIH MANUAL "BIOSAFETY IN MICROBIOLOGICAL 
AND BIOMEDICAL LABORATORIES, FROM POTENTIALLY INFECTIOUS HUMAN 
SERUM OR BLOOD SPECIMENS" 
THE MATERIAL LISTED ON THIS CERTIFICATE OF ANALYSIS HAS BEEN 
TESTED IN ACCORDANCE WITH FDA REGULATIONS AND FOUND TO BE 
NEGATIVE FOR HIV AB AND HCV AB AND NON-REACTIVE FOR HBSAG, HIV-I RNA, 
HCV RNA, HBV DNA, "'NV RNA, ANTI-T. CRUZI, ZIKA VIRUS RNA AND STS. 
THIS PRODUCT IS' BEING SOLD FOR RESEARCH AND OR MANUFACTURING 
PURPOSES ONLY. IT IS NOT TO 
BE USED IN HUMANS OR ANIMALS AND FURTHER MANUFACTURING THA T 
WILL RESUL T IN A FINISHED PRODUCT THAT CONTAINS VIABLE LEUKOCYTES IS 
PROHIBITED. FOR IN VITRO USE ONLY. THE USER 
ASSUMES ALL RESPONSIBILITY FOR ITS USAGE AND DISPOSAL IN 






PRODUCT: HUMAN WHOLE BLOOD 
CATALOG # HMWBNAHP 
ANTICOAGULANT: SODIUM HEPARIN 
LOT#: BRH1399237 
STORAGE TEMPERATURE: 4 0 C 
COA DATE: 190CT2017 
PURCHASE ORDER: VISA 
PROJECT NUMBER: 1268023 
VOLUME SHIPPED: 100 ML 




BIOHAZARD INFO: THIS MATERIAL SHOULD BE HANDLED AS IF CAPABLE 
OF TRANSMITTING INFECTIOUS AGENTS. PLEASE USE UNIVERSAL PRECAUTIONS. 
NO TEST METHOD CAN PROVIDE 
TOTAL ASSURANCE THAT HEPATITIS B VIRUS, HEPATITIS C VIRUS, HUMAN 
IMMUNODEFICIENCY VIRUS, OR OTHER INFECTIOUS AGENTS ARE ABSENT. 
THUS, ALL BIOLOGICAL PRODUCTS THAT WE 
PROVIDE SHOULD BE HANDLED AT THE BIO-SAFETY LEVEL 2 AS 
RECOMMENDED BY THE CDC/NIH MANUAL "BIOSAFETY IN MICROBIOLOGICAL 
AND BIOMEDICAL LABORATORIES, FROM POTENTIALLY INFECTIOUS HUMAN 
SERUM OR BLOOD SPECIMENS" 
THE MATERIAL LISTED ON THIS CERTIFICATE OF ANALYSIS HAS BEEN 





NEGATIVE FOR HIV 1/2 AB AND HCV AB AND NON-REACTIVE FOR HBSAG, HIV-I 
RNA, HCV RNA, HBV DNA, WNV RNA, ANTI-T. CRUZI, ZIKA VIRUS RNA AND STS. 
THIS PRODUCT IS BEING SOLD FOR RESEARCH AND OR MANUFACTURING 
PURPOSES ONLY. IT IS NOT TO 
BE USED IN HUMANS OR ANIMALS AND FURTHER MANUFACTURING THAT WILL RESULT IN A 
FINISHED PRODUCT THAT CONTAINS VIABLE LEUKOCYTES IS PROHIBITED. FOR IN VITRO USE ONLY. THE 
USER 
ASSUMES ALL RESPONSIBILITY FOR ITS USAGE AND DISPOSAL IN 






PRODUCT: HUMAN SERUM 
CATALOG # HMSRM 
ANTICOAGULANT: 
NONE LOT#: BRH1215150 




PROJECT NUMBER: 1216074 
VOLUME SHIPPED: 25 ML 
PRESENTATION: 1 LOT OF 25 ML (1 X 25 ML) OF 





BIOHAZARD INFO: THIS MATERIAL SHOULD BE HANDLED AS IF 
CAPABLE OF TRANSMITTING INFECTIOUS AGENTS. PLEASE USE 
UNIVERSAL PRECAUTIONS. NO TEST METHOD CAN PROVIDE 
TOTAL ASSURANCE THAT HEPATITIS B VIRUS, HEPATITIS C VIRUS, 
HUMAN IMMUNODEFICIENCY VIRUS, OR OTHER INFECTIOUS AGENTS 
ARE ABSENT. THUS, ALL BIOLOGICAL PRODUCTS THAT WE 
 
PROVIDE SHOULD BE HANDLED AT THE BIO-SAFETY LEVEL 2 AS 
RECOMMENDED BY THE CDC/NIH MANUAL "BIOSAFETY IN 
MICROBIOLOGICAL AND BIOMEDICAL LABORATORIES, FROM 
POTENTIALLY INFECTIOUS HUMAN SERUM OR BLOOD SPECIMENS" 
 
THE MATERIAL LISTED ON THIS CERTIFICATE OF ANALYSIS HAS 
BEEN TESTED IN ACCORDANCE WITH FDA REGULATIONS AND FOUND 
TO BE NEGATIVE FOR HIV 1/2 AB AND HCV AB AND NON-REACTIVE FOR 
HBSAG, HIV-I RNA, HCV RNA, HBV DNA AND STS. 
THIS PRODUCT IS BEING SOLD FOR RESEARCH AND OR 
MANUFACTURING PURPOSES ONLY. IT IS' NOT TO 
BE USED IN HUMANS OR ANIMALS AND FURTHER MANUFACTURING 
THAT WILL RESULT IN A FINISHED PRODUCT THATCONTAINS' VIABLE 





ASSUMES ALL RESPONSIBILITY FOR ITS USAGE AND DISPOSAL IN 
ACCORDANCE WITH ALL REGULA TIONS. 
 1  T 516 483  4683 E  
rx.4 
PRODUCT: HUMAN RED BLOOD CELLS (SODIUM HEPARIN) 
 
BRH1215151 STORAGE TEMPERATURE: 4 0 C 
COA DATE: 31AUG2016 
PURCHASE ORDER: VISA 
PROJECT NUMBER: 1216074 
VOLUME SHIPPED: 25 ML 
PRESENTATION: 1 LOT OF 25 ML (1 X 25 ML) OF 
HUMAN 
RED BLOOD CELLS (SODIUM 
HEPARIN) 
EXPIRATION: 30SEP2016 
BIOHAZARD INFO: THIS MATERIAL SHOULD BE HANDLED AS IF 
CAPABLE OF TRANSMITTING INFECTIOUS AGENTS. PLEASE USE 
UNIVERSAL PRECAUTIONS. NO TEST METHOD CAN PROVIDE 
TOTAL ASSURANCE THAT HEPATITIS B VIRUS, HEPATITIS C VIRUS, 
HUMAN IMMUNODEFICIENCY 
VIRUS, OR OTHER INFECTIOUS AGENTS ARE ABSENT. THUS, ALL 





PROVIDE SHOULD BE HANDLED AT THE BIO-SAFETY LEVEL 2 AS 
RECOMMENDED BY THE CDC/NIH MANUAL "BIOSAFETY IN 
MICROBIOLOGICAL AND BIOMEDICAL LABORATORIES, FROM 
POTENTIALLY INFECTIOUS HUMAN SERUM OR BLOOD SPECIMENS" 
THE MATERIAL LISTED ON THIS CERTIFICATE OF ANALYSIS HAS 
BEEN TESTED IN ACCORDANCE WITH FDA REGULATIONS AND FOUND 
TO BE NEGATIVE FOR HIV AB AND HCV AB AND NON-REACTIVE FOR 
HBSAG, HIV-I RNA, HCV RNA, HBV DNA, WNV RNA, ANTI-T. CRUZI AND 
STS. 
THIS PRODUCT IS BEING SOLD FOR RESEARCH AND OR 
MANUFACTURING PURPOSES ONLY. IT IS' NOT TO 
BE USED IN HUMANS OR ANIMALS AND FURTHER MANUFACTURING THAT WILL RESULT IN A 
FINISHED PRODUCT THAT CONTAINS' VIABLE LEUKOCYTES IS PROHIBITED. FOR IN VITRO USE ONLY. 
THE USER 
ASSUMES' ALL RESPONSIBILITY FOR ITS USAGE AND DISPOSAL IN 






COA DATE: 31AUG2016 




VOLUME SHIPPED: 50 ML 




BIOHAZARD INFO:THIS MATERIAL SHOULD BE HANDLED AS IF CAPABLE 
OF TRANSMITTING 
INFECTIOUS AGENTS. PLEASE USE UNIVERSAL PRECAUTIONS. NO 
TEST METHOD CAN PROVIDE 
TOTAL ASSURANCE THAT HEPATITIS B VIRUS, HEPATITIS C VIRUS, 
HUMAN IMMUNODEFICIENCY VIRUS, OR OTHER INFECTIOUS AGENTS 
ARE ABSENT. THUS, ALL BIOLOGICAL PRODUCTS THAT WE 
PROVIDE SHOULD BE HANDLED AT THE BIO-SAFETY LEVEL 2 AS 
RECOMMENDED BY THE CDC/NIH MANUAL "BIOSAFETY IN 
MICROBIOLOGICAL AND BIOMEDICAL LABORATORIES, FROM 





THE MATERIAL LISTED ON THIS CERTIFICATE OF ANALYSIS HAS BEEN 
TESTED IN ACCORDANCE WITH FDA REGULATIONS AND FOUND TO BE 
NEGATIVE FOR HIV 1/2 AB AND HCV AB AND NON-REACTIVE FOR HBSAG, 
HIV-I RNA, HCV RNA, HBV DNA, WNV RNA, ANTI-T. CRUZI AND STS. 
THIS PRODUCT IS BEING SOLD FOR RESEARCH AND OR 
MANUFACTURING PURPOSES' ONLY. IT IS NOT TO 
BE USED IN HUMANS OR ANIMALS AND FURTHER MANUFACTURING THAT WILL RESULT IN A 
FINISHED 
PRODUCT THAT CONTAINS VIABLE LEUKOCYTES IS PROHIBITED. FOR 
IN VITRO USE ONLY. THE USER 
ASSUMES ALL RESPONSIBILITY FOR ITS USAGE AND DISPOSAL IN 





















bloodstain measurements with caliper bloodstain measurements 400% on screen with caliper
very high density very high density
7.1 10 degrees W L W/L Angle 7.1  10 degrees W L W/L Angle
1 4.37 31.63 0.14 8.04 1 12.76 93.87 0.14 8.04
2 4.43 30.87 0.14 8.04 2 11.96 93.64 0.13 7.46
3 4.57 30.65 0.15 8.62 3 11.77 93.85 0.13 7.46
4 4.63 31.24 0.15 8.62 4 12.14 92.66 0.13 7.46
5 4.51 31.39 0.14 8.04 5 11.24 91.75 0.12 6.89
6 4.75 30.86 0.15 8.62 6 11.82 92.57 0.13 7.46
7 4.49 30.98 0.14 8.04 7 11.54 93.08 0.12 6.89
8 4.39 31.39 0.14 8.04 8 11.96 91.07 0.13 7.46
9 4.41 30.51 0.14 8.04 9 11.48 92.68 0.12 6.89
10 4.62 30.79 0.15 8.62 10 11.82 91.10 0.13 7.46
mean 4.51 31.03 0.14 8.27 mean 11.84 92.61 0.13 7.35
SD 0.123 0.364 0.00516 0.299 SD 0.414 1.06 0.00632 0.362
RSD 2.74% 1.17% 3.59% 3.62% RSD 3.50% 1.14% 4.94% 4.94%
7.1 55 degrees 7.1  55 degrees
1 11.51 14.45 0.80 53.13 1 31.51 38.76 0.81 54.09
2 11.39 14.65 0.78 51.26 2 30.32 39.23 0.77 50.35
3 11.71 14.08 0.83 56.09 3 30.26 38.43 0.79 52.18
4 11.72 14.41 0.81 54.09 4 30.65 38.84 0.79 52.18
5 11.73 14.29 0.82 55.08 5 30.07 38.52 0.78 51.26
6 12.03 13.81 0.87 60.46 6 30.09 38.40 0.78 51.26
7 11.56 14.42 0.80 55.13 7 30.31 38.49 0.79 52.18
8 11.58 14.34 0.81 54.09 8 31.25 38.63 0.81 54.09
9 11.83 14.23 0.83 56.09 9 30.30 38.67 0.78 51.26
10 11.17 14.46 0.77 50.35 10 30.01 38.42 0.78 51.26
mean 11.62 14.31 0.81 54.58 mean 30.47 38.63 0.79 52.01
SD 0.239 0.233 0.0282 2.81 SD 0.511 0.256 0.0131 1.23
RSD 2.06% 1.63% 3.47% 5.15% RSD 1.68% 0.66% 1.67% 2.38%
7.1 90 degrees 7.1  90 degrees
1 13.33 13.90 0.96 73.73 1 45.07 45.95 0.98 78.52
2 13.67 14.12 0.97 75.93 2 44.03 45.42 0.97 75.93
3 14.04 14.43 0.97 75.93 3 44.52 45.44 0.98 78.52
4 13.64 14.11 0.97 75.93 4 43.70 45.72 0.96 73.73
5 14.05 14.19 0.99 81.89 5 43.94 45.87 0.96 73.73
6 13.95 13.91 1.00 90.00 6 44.04 46.16 0.95 71.80
7 13.91 14.46 0.96 73.73 7 43.92 46.04 0.95 71.80
8 14.16 14.32 0.99 81.89 8 45.38 45.50 1.00 90.00
9 14.10 14.45 0.98 78.52 9 43.90 45.30 0.97 75.93
10 13.61 14.11 0.96 73.73 10 44.09 46.00 0.96 73.73
mean 13.86 14.20 0.97 78.13 mean 44.25 45.74 0.97 76.37
SD 0.269 0.209 0.0143 5.18 SD 0.554 0.305 0.0154 5.35













bloodstain measurements with caliper bloodstain measurements 400% on screen with caliper
normal density W L W/L Angle normal density W L W/L Angle
5.1  10 degrees 5.1  10 degrees
1 5.06 31.75 0.16 9.20 1 17.35 110.59 0.16 9.20
2 5.12 31.88 0.16 9.20 2 17.49 114.72 0.15 8.62
3 5.07 33.97 0.15 8.62 3 16.90 125.44 0.13 7.46
4 5.51 32.13 0.17 9.78 4 17.98 122.77 0.15 8.62
5 5.18 32.02 0.16 9.20 5 15.21 125.58 0.12 6.89
6 5.14 32.07 0.16 9.20 6 16.24 124.17 0.13 7.46
7 4.93 33.78 0.15 8.62 7 17.21 121.11 0.14 8.04
8 5.28 32.40 0.16 9.20 8 16.57 120.17 0.14 8.04
9 5.17 31.56 0.16 9.20 9 16.38 120.48 0.14 8.04
10 5.35 31.28 0.17 9.78 10 16.54 118.22 0.14 8.04
mean 5.18 32.28 0.16 9.20 mean 16.78 120.32 0.14 8.04
SD 0.164 0.895 0.00666 0.386 SD 0.780 4.782 0.0115 0.667
RSD 3.17% 2.77% 4.17% 4.20% RSD 4.65% 3.97% 8.25% 8.31%
5.3  55 degrees 5.3  55 degrees
1 14.94 19.73 0.76 49.46 1 65.93 87.56 0.75 48.59
2 15.22 19.61 0.78 51.26 2 64.54 87.63 0.74 47.73
3 15.01 18.99 0.79 52.18 3 67.67 86.84 0.78 51.26
4 14.90 19.36 0.77 50.35 4 65.45 86.90 0.75 48.59
5 15.09 19.09 0.79 52.18 5 65.83 85.84 0.77 50.35
6 15.28 18.61 0.82 55.08 6 66.55 87.62 0.76 49.46
7 15.20 19.09 0.80 53.13 7 64.89 85.98 0.75 48.59
8 15.41 19.07 0.81 54.09 8 65.90 86.69 0.76 49.46
9 15.34 19.51 0.79 52.18 9 66.06 86.40 0.76 49.46
10 15.21 19.21 0.79 52.18 10 66.55 86.20 0.77 50.35
mean 15.16 19.22 0.79 52.21 meab 65.93 86.76 0.76 49.38
SD 0.17 0.332 0.0176 1.65 SD 0.886 0.672 0.0119 1.055
RSD 1.12% 1.73% 2.23% 3.16% RSD 1.34% 0.77% 1.58% 2.14%
5.5  90 degrees 5.5 90 degrees
1 16.39 16.69 0.98 78.52 1 42.60 43.95 0.97 75.93
2 16.31 16.78 0.97 75.93 2 42.29 43.52 0.97 75.93
3 16.45 16.44 1.00 90.00 3 42.86 43.98 0.97 75.93
4 16.12 16.70 0.97 75.93 4 43.07 42.86 1.00 90.00
5 16.56 17.31 0.96 73.73 5 42.42 44.31 0.96 73.73
6 16.18 16.86 0.96 73.73 6 43.03 44.43 0.97 75.93
7 16.31 16.61 0.98 78.52 7 41.83 43.28 0.97 75.93
8 16.59 16.65 1.00 90.00 8 42.75 44.25 0.97 75.93
9 16.47 16.81 0.98 78.52 9 43.15 43.54 0.99 81.89
10 16.57 16.74 0.99 81.89 10 43.79 43.67 1.00 90.00
mean 16.39 16.75 0.98 79.68 mean 42.77 43.77 0.98 79.12
SD 0.163 0.226 0.0144 5.97 Sd 0.539 0.497 0.0141 6.096













bloodstain measurements with caliper bloodstain measurements 400% on screen with caliper
very low density W L W/L Angle very low density W L W/L Angle
1.5  10 degrees 1.5  10 degrees
1 4.95 43.14 0.11 6.31 1 14.30 102.74 0.14 8.04
2 5.27 42.64 0.12 6.89 2 15.30 103.42 0.15 8.62
3 5.17 44.02 0.12 6.89 3 14.51 103.36 0.14 8.04
4 5.37 42.41 0.13 7.46 4 14.36 99.69 0.14 8.04
5 5.04 43.34 0.12 6.89 5 14.72 108.42 0.14 8.04
6 5.39 43.82 0.12 6.89 6 14.04 108.6 0.13 7.46
7 5.23 43.10 0.12 6.89 7 14.00 106.00 0.13 7.46
8 5.17 41.97 0.12 6.89 8 15.01 105.85 0.14 8.04
9 5.08 41.17 0.12 6.89 9 14.47 106.80 0.14 8.04
10 5.58 43.01 0.13 7.46 10 13.44 102.92 0.13 7.46
mean 5.22 42.86 0.12 6.95 mean 14.41 104.78 0.14 7.92
SD 0.186 0.853 0.00567 0.325 SD 0.529 2.827 0.00632 0.366
RSD 3.50% 1.99% 4.69% 4.69% RSD 3.67% 2.70% 4.58% 4.63%
1.4  55 degrees 1.4  55 degrees
1 13.60 17.40 0.78 51.26 1 50.16 66.34 0.76 49.46
2 14.00 17.42 0.80 53.13 2 50.72 65.89 0.77 50.35
3 14.08 16.52 0.85 58.21 3 51.51 65.61 0.79 52.18
4 14.04 16.86 0.83 56.09 4 51.75 65.28 0.79 52.18
5 13.77 17.33 0.79 52.18 5 50.45 65.59 0.77 50.35
6 14.09 17.59 0.80 53.13 6 51.41 64.55 0.80 53.13
7 14.01 17.28 0.81 54.09 7 50.72 66.70 0.76 49.46
8 13.61 16.93 0.80 53.13 8 51.65 65.51 0.79 52.18
9 13.72 17.51 0.78 51.26 9 51.15 65.81 0.78 51.26
10 13.93 17.25 0.81 54.09 10 52.20 64.87 0.80 53.13
mean 13.88 17.20 0.80 53.66 mean 51.17 65.61 0.78 51.37
SD 0.192 0.335 0.0217 2.14 SD 0.645 0.635 0.0152 1.39
RSD 1.38% 1.95% 2.70% 4.00% RSD 1.26% 0.97% 1.95% 2.72%
1.2  90 degrees 1.2  90 degrees
1 17.30 18.11 0.96 73.73 1 67.92 69.46 0.98 78.52
2 17.18 17.68 0.97 75.93 2 68.55 69.53 0.99 81.89
3 17.28 17.50 0.99 81.89 3 68.05 69.20 0.98 78.52
4 17.64 17.59 1.00 90.00 4 65.90 68.58 0.96 73.73
5 17.33 17.45 0.99 81.89 5 65.89 68.94 0.96 73.73
6 17.25 17.62 0.98 78.52 6 67.32 68.89 0.98 78.52
7 17.44 17.77 0.98 78.52 7 67.36 69.47 0.97 73.73
8 17.26 17.96 0.96 73.73 8 66.96 68.42 0.98 78.52
9 17.58 18.04 0.97 75.93 9 66.46 68.44 0.97 73.73
10 16.98 17.78 0.96 73.73 10 67.33 68.59 0.98 78.52
mean 17.32 17.75 0.98 78.39 mean 67.17 68.95 0.98 76.94
SD 0.191 0.225 0.0142 5.12 SD 0.889 0.439 0.00971 2.94











































measurements taken from constructed triangles
using digital angle finder
30,60,90 right triangle
60 degrees 30 degrees 90 degrees
1 59.7 29.6 89.6
2 59.6 29.8 89.9
3 59.8 29.8 90.0
4 59.6 30.3 89.1
5 59.6 30.00 89.7
mean 59.7 29.9 89.6
SD 0.0894 0.264 0.350
RSD 0.15% 0.88% 0.39%























45 degrees 45 degrees 90 degrees
1 44.4 44.6 89.6
2 44.3 44.9 90.5
3 44.3 44.7 90.6
4 44.6 44.8 90.7
5 44.5 44.7 90.1
mean 44.4 44.7 90.3
SD 0.130 0.114 0.452
RSD 0.29% 0.25% 0.50%
error 1.29% 0.58% 0.33%
3,4,5 right triangle
53.1 degrees 36.9 degrees 90 degrees
1 52.7 36.5 89.6
2 52.6 36.4 89.7
3 52.8 36.5 90.1
4 52.9 36.4 90.0
5 53.0 36.7 90.1
mean 52.8 36.5 89.9
SD 0.158 0.122 0.234
RSD 0.30% 0.34% 0.26%























Study 1 Bloodstain Photographs 
The number designations for the bloodstain pictures is the following 
Impact angle, number indicating stain density, number of bloodstain in the sequence. 
1: very low density 
2: low density      
3: normal density 
4: high density   
5: very high density           
 
Example 



















10°  1-1 10°  1-4 
10°  1-2 
10°  1-5 
10°  1-3 






10°  1-7 10°  1-10 
10°  1-8 







25°  1-1 25°  1-4 
25°  1-2 
25°  1-5 
25°  1-3 






25°  1-7 25°  1-10 
25°  1-8 






40°  1-1 40°  1-4 
40°  1-2 40°  1-5 
40°  1-3 






40°  1-7 40°  1-10 
40°  1-8 







55°  1-1 55°  1-4 
55°  1-2 55°  1-5 
55°  1-3 






55°  1-7 55°  1-10 
55°  1-8 







70°  1-1 70°  1-4 
70°  1-2 70°  1-5 
70°  1-3 






70°  1-7 70°  1-10 
70°  1-8 






90°  1-1 90°  1-4 
90°  1-2 90°  1-5 
90°  1-3 






90°  1-7 90°  1-10 
90°  1-8 






10°  3-1 
10°  3-4 
10°  3-2 10°  3-5 
10°  3-3 






10°  3-7 10°  3-10 
10°  3-8 






25°  3-1 25°  3-4 
25°  3-2 25°  3-5 
25°  3-3 






25°  3-7 25°  3-10 
25°  3-8 







40°  3-1 40°  3-4 
40°  3-2 40°  3-5 
40°  3-3 






40°  3-7 
40°  3-10 
 
40°  3-8 







55°  3-1 55°  3-4 
55°  3-2 55°  3-5 
55°  3-3 






55°  3-7 55°  3-10 
55°  3-8 







70°  3-1 70°  3-4 
70°  3-2 70°  3-5 
70°  3-3 






70°  3-7 70°  3-10 
70°  3-8 






90°  3-1 90°  3-4 
90°  3-2 90°  3-5 
90°  3-3 






90°  3-7 90°  3-10 
90°  3-8 






10°  5-1 10°  5-4 
 
10°  5-2 10°  5-5 
 
10°  5-3 
 







10°  5-7 10°  5-10 
10°  5-8 







25°  5-1 25°  5-4 
25°  5-2 25°  5-5 
25°  5-3 






25°  5-7 25°  5-10 
25°  5-8 






40°  5-1 40°  5-4 
40°  5-2 40°  5-5 
40°  5-3 






40°  5-7 40°  5-10 
40°  5-8 






55°  5-1 55°  5-4 
55°  5-2 55°  5-5 
55°  5-3 






55°  5-7 55°  5-10 
55°  5-8 






70°  5-1 70°  5-4 
70°  5-2 70°  5-5 
70°  5-3 






70°  5-7 70°  5-10 
70°  5-8 






90°  5-1 90°  5-4 
90°  5-2 90°  5-5 
90°  5-3 






90°  5-7 90°  5-10 
90°  5-8 






10°  6-1 10°  6-4 
 
10°  6-2 10°  6-5 
 
10°  6-3 
 







10°  6-7 
10°  6-10 
10°  6-8 







25°  6-1 25°  6-4 
25°  6-2 25°  6-5 
25°  6-3 






25°  6-7 25°  6-10 
25°  6-8 






40°  6-1 40°  6-4 
40°  6-2 40°  6-5 
40°  6-3 






40°  6-7 40°  6-10 
40°  6-8 






55°  6-1 55°  6-4 
55°  6-2 55°  6-5 
55°  6-3 






55°  6-7 55°  6-10 
55°  6-8 






70°  6-1 70°  6-4 
70°  6-2 70°  6-5 
70°  6-3 






70°  6-7 70°  6-10 
70°  6-8 






90°  6-1 90°  6-4 
90°  6-2 90°  6-5 
90°  6-3 






90°  6-7 90°  6-10 
90°  6-8 






10°  7-1 10°  7-4 
10°  7-2 10°  7-5 
10°  7-3 






10°  7-7 10°  7-10 
10°  7-8 






25°  7-1 25°  7-4 
25°  7-2 25°  7-5 
25°  7-3 






25°  7-7 25°  7-10 
25°  7-8 






40°  7-1 40°  7-4 
40°  7-2 40°  7-5 
40°  7-3 






40°  7-7 40°  7-10 
40°  1-8 






55°  7-1 
55°  7-4 
 
55°  7-2 
55°  7-5 
 
55°  7-3 
 







55°  7-7 55°  7-10 
 
55°  7-8 







70°  7-1 70°  7-4 
 
70°  7-2 
 
70°  7-5 
 
70°  7-3 
 







70°  7-7 70°  7-10 
 
70°  7-8 







90°  7-1 90°  7-4 
 
90°  7-2 
 
90°  7-5 
 
90°  7-3 
 








90°  7-7 90°  7-10 
 
90°  7-8 






Confidence Interval Explanation and Example 
  
The formula to calculate a 95% confidence interval is: 
M ± t (N–1) × SE 
where M = mean value of a sample of data; t (N–1) is the critical value of the t statistic at p 
= .05 when the sample size is N; SE is the standard error of the mean, given by σ/√N, (where σ = 
standard deviation of the sample of data).   
 For example, the known mean location of the (area) volume  of origin and the 
95% CI of the mean at Blood Density = 1 is calculated using data for five sets of observations 
(numbered by 1.1, 1.2, 1.3, 1.4, and 1.5) at points x, y, and z as follows: 
Blood 
Density Observation Point 
Known Area of Origin 
(cm) 
1 1.1 x 31.00 
1 1.1 y 119.00 
1 1.1 z 45.00 
1 1.2 x 31.00 
1 1.2 y 119.00 
1 1.2 z 45.00 
1 1.3 x 28.00 
1 1.3 y 119.00 
1 1.3 z 45.00 
1 1.4 x 24.00 
1 1.4 y 108.00 
1 1.4 z 47.00 
1 1.5 x 24.00 
1 1.5 y 108.00 
1 1.5 z 47.00 
       
Calculation of 95% CI of mean 
  Sample size N 15.00 
  Mean M 62.67 
  Standard Deviation σ 38.96 






t test statistic at 
p = .05   2.14 
  
t x Standard 
Error   21.58 
  
Lower limit of 
95% CI 
 M - (t x Standard 
Error) 41.09 
  
Upper limit of 
95% CI 
 M  + (t x Standard 
Error) 84.24 
 
 The mean (M = 62.67) and the 95% CI (lower limit = 41.09; upper limit = 84.24) 
of the known area of origin  at points x, y, and z using Blood Density = 1 calculated in the above 
table are represented by the first point and vertical bar on the extreme left-hand side of the 
































Confirmation of Polymer Composition by FT-IR 
Confirmation of Polymer Composition by FT-IR employing Thermo Fisher Nicolet 6500 
with spectra taken in transmission mode and displayed as absorbance vs.  cm-1 all spectra 




Omnic (Themo-Fisher software) search of data base HR Nicolet Sampler and Hummel 









Omnic (Themo-Fisher software) search of data base HR Nicolet Sampler and Hummel 














Top spectra collected from employed polymer material bottom spectra from Internet 






Take away. Polymer materials purchased for and used for blood contact angle 
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